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1INTRODUCTION
Siddha system is one of the oldest system of medicine in India. The word
“Siddha” comes from the word “siddhi”, which means an object to attain
perfection or heavenly bliss. Siddha generally refers to Attama siddhi that is the
Eight Super Natural Powers those who attained or achieved the above said
powers are know as “Siddhars” Siddhars were saintly figures. There were
eighteen important siddhars in olden days and they developed this
medicine.
Origin :
The origin of siddha system of medicine, traces back to the submerged
Lemurian continent. Its was conceived and crafted by the ancient siddhars who's
principle Language was Tamil. The origin of the system and the usaged of
medicinal plants belongs to the age of the Sangam Literatures as early as 3000
B.C. "Tholkappiam" and "Thirumanthiram" stands as a proof to this.
Basic principles :
Siddha system of medicine is based on "Saiva Siddhantha". The prime
principle of saiva siddhantha is to become one with the gods almighty and that is
determined as a goal of life. The goal of life can be achieved by keeping the
health of our mortal body. The could be known by Thirumoolar in line, which
says,
clk;ghh; mopapy; capuhh; mopth;
jplk;gl nka;Qhdk; NruTk; khl;lhh;
clk;ig tsh;f;Fk; cghak; mwpe;Nj
clk;ig tsh;j;Njd; caph; tsh;e;NjNd!
- jpUke;jpuk;
2Siddha science considers nature and man as essentially one. Nature is
man and man is nature. Man is said to be the microcosm and universe is the
macrocosm because what exists in the world exists in man. Man is nothing but a
miniature   world, containing the five elements of various principles which
constitute the minerals plants, and animal kingdom.
“mz;lj;jpy; cs;sNj gpz;lk;
gpz;lj;jpy; cs;sNj mz;lk;
mz;lKk; gpz;lKk; xd;Nw
mwpe;Jjhd; ghh;f;Fk; NghNj”
- rl;lKdp Qhdk;
According to siddha medical science, the universe originally. Consisted
of atoms which   contributed to the five basic elements. Viz.,
Prithivi - Earth
Appu - Water
Theyu - Fire
Vayu - Air
Agayam - Sky
Among these elements.
 Earth - gives fine shapes to the body includes bones tissue,
muscles, skin, hair, etc,
 Water - represents for blood secretions of the gland, vital fluid etc.
 Fire - gives motion, vigor and vitality to the body.
3These three elements are primarily responsible for the formation of three
humours,
 Vatham
 Pitham
 Kabam.
These are the three fundamental functional constituents of human body
and these are supposed to be in the proportion of 1: Vi : % in a healthy individual
and are known as uMuthathukkal"(Kj;jhJf;fs;).But when this equilibrium is
disarranged these are known as mukkutrangal (Kf;Fw;wq;fs;) which lead to
disease. This principle is quoted by Thiruvalluvar as
kpfpDk; FiwapDk; Neha;nra;Ak; E}Nyhh;
tspKjyh vz;zpa %d;W
- jpUf;Fws;
The Fundamental subjects of Siddha methodology
1. Vadham (Alchemy)
2. Vaithiyam (Medicine)
3. Yogam (Yoga)
4. Gyanam or Thathuvam (Philosophy)
Meateria Medica :
The siddha system has three classifications over the sources of the drug.
They are
 Mooligai vaguppu - plant sources.
 Thathu Vaguppu - metal and mineral sources
 Jeeva Vaguppu- animal sources.
The Thathu Vaguppu which deals with metals and minerals further
classified into four types.
4They are
1. Ulogam (metals)
Classes of metals, there are eleven in numbers.
2. Karasaaram (Alkalies & Salts)
These are 25 varieties of watersoluble in-organic compound called uppu.
3. Padaanum:
These are 64 varieties of minerals drugs that do not dissolve in water but
emit vapour when put in fire.
4. Uparasam:
These are 120 in number.
Chemistry in siddha system.
In siddha system, chemistry had been found well developed into science
auxilliary to medicine and alchemy. It was found useful in the preparation of
medicine as well as in transmutation of basic metals into gold. The siddhars were
aware of several chemical operations divided into several process such as :
 Calcination
 Sublimation
 Distillation
 Fusion
 Separation
 Fermentation
 Exaltation etc.
5Importance of toxicology and toxicity study :
Toxicology is the branch of medical science which deals with poisons
with reference of their source, characters and properties etc. A poison is
commonly defined as a substance which, when administered, inhaled or
swallowed in capable of acting deteriously on the body. Thus almost anything is
poison.
There is actually no boundary between a medicine and a poison, for a
medicine in toxic dose is a poison and poison in a small dose may be a medicine.
The real difference between a medicine and a poison is the intend with which it
is given. There are main factors which modify the action of poisons. They are
1.Quantity, 2.Form, 3. Mode of administration and 4. condition of the body.
In fact, these four factors are the lying boundaries between toxic property
of an administered drug. Hence to reveal the actual status of a drug, over the
administered body, we should go for toxic study of the drug. It will give a broad
idea about the drug, towards its therapeutic value, lethal dose, and symptoms
which they produce. Hence, the toxic study of a drug will be the best preface for
its therapeutic episode.
Toxicology in siddha system :
Too much of anything is good for nothing. Which is the actual meaning
of Tamil proverb,
msTf;F kPwpdhy; mkph;jKk; eQ;rhFk;.
This is also explained by Thiruvalluvar as
“gPypnga; rhfhLk; mr;rpWk; mg;gz;lk;>
rhy kpFj;Jg; ngapd;.”
6In this materialistic world each and every object has two characters good
and bad, which are lying invariably among them. So, whenever we go to prepare
a medicine. We should remove the toxins and unwanted materials from them.
In our country, toxic plants and materials were identified more than 5000
years ago, itself. In that time poisons are used with food stuffs to kill the
enemies or to steal the property of our kingdom. Poisons are also used in the
weapons for hunting.
Siddhars like Agasthiyar and Bogar were knew the usage of toxins. They
were well versed about the purification, lethal dose, therapeutic dose and usage,
of the toxins. “Seevaka chinthamani” in a samana literature gives details about
the usage of toxic materials to kill or mesmerise the enemies. It also gives idea
to identify those toxic materials from food, cloth, beverages etc.
By keeping all these facts in mind the author had selected Thetran
Choornam for this dissertation study.  This study makes a detailed idea about
the toxicity of the drug.
7AIMS AND OBJECTIVES
The aim of this study is to evaluate the toxicological profile of
“THETRAN CHOORNAM”.
Objectives
 To collect and purify the raw materials based on literature
evidence.
 To perform compound analysis for the purified raw drug samples.
 To prepare the medicine based on Siddha literary evidence.
 To estimate the presence of chemical constituents by performing
elemental analysis.
 To analyse its safety the medicine is subjected for acute oral
toxicity evaluation on rodents when the drug is given in single
dose through oral administration at various dose levels.
 To analyse its safety the medicine is subjected for Chronic oral
toxicity study evaluation on rodents when the drug is given in for a
long time.
 If the outcome of safety study does not exhibit and mortality /
morbidity then it will be subjected for pharmacological study in
future to assess its efficacy and also we will prescribe the thetran
chooranam under ethics as clinical.
8THALAGAM
9ARSENIC TRISULPHIDE AS2S3
Vernacular Name
Arab - Ursanigum
Bengali - Haritala
English - Yellow Arsenic trisulphide
Sanskrit - Mah
Telugu - Daddipashnum
Tamil - Haritaram, Thalagam, Yellikud Pashanam
Haritaram is found native in China and Persia. Orpiment occurs in two
forms, in smooth shining; gold coloured scales called “Vanaspatri Haritala” and
in fine lemon yellow opaque masses called “Pinda Haritala”. The former is
preferred for internal use as an alternative and febrifuge.
- Dr. K.M. Nadkarni’s, Indian Materia Medica – Valume I
mhpjhuk;
mhpjhuk; irjd;a nghUl;fspy; ,uz;lhtJ MFk;. fe;jf
rk;ge;jj;jpdhy; nre;J}uq;fshtJ NghyNt ,jd; rk;ge;jj;jpdhYk;
nre;J}uq;fs; nra;ag;gLfpd;wgbahy; ,JTk; xU Kjd;ik ,urthj
fh;j;jhntdr; nrhy;yg;gLfpd;wJ.
“nre;J}uj;jpw;F Mjp rpiyf; fe;jp jhsfk;”
,J fe;jfj;ijg; NghyNt gpwtpr; ruf;F. ,jpy; tq;fr; rj;J
,Uf;fpwJ vd;gij ,urthj gz;bjh;fs; Neh;KfkhfTk;> mDNghf
rpj;jkhfTk; fz;L epr;rapj;J ,Uf;fpwhh;fs;.
- Mjhuk; - mDNghf itj;jpa etePjk;> ghfk; - 6 gf;fk; 69
“mhpjhug; nghd;Df;F `hdpapy;iy” vd;fpw xU gonkhopahy;
mhpjhuk; Ntijapy; xU Kf;fpa ruf;fhFk;. mhpjhuj;jpy; ,Ue;J gphpj;J
vLf;fg;gLk;. tq;fk;> nrk;gpy; nfhLf;f th;zpf;Fk; vd;Wk;
nrhy;yg;gLfpwJ. ,J Muha;r;rpf;F chpaJ.
Mjhuk; - Fzghlk; jhJ rPt tFg;G gf;fk; 242
10
ghlhzk; 64-y; jhsfk;> ,aw;if ghlhz tifiar; rhh;e;jJ
vd;gij>
“jhnkd;w ypq;fg;gh lhzj; NjhL
rufz;le; jhsfe;jhd; rpiyA khFk;
Ntjnkd;Nw MTgy;gh lhzj;NjhL
tpsf;fkhQ; rhyhq;fq; fw;ghpA khNk”
- Nghfh; - 7000
nra;Ashy; mwpayhk;.
jhsfk; NtW ngah;fs; :
gPjfp> Myk;gp> gpQ;rdk;> gOg;G> Nfhje;jk;> khyk;> jhsfk;>
fhy;Gj;jp> nghd;th;zp> kQ;rs;th;zp> khy;Njtp> mhpjsk;.
- Fzghlk; jhJ rPt tFg;G gf;fk; 242
jkpopy; :
khy;ghfk;> khy;Njtp> jhsfk;> ,yl;Rkp> Nfhje;jp> gPjfk;> ruk;kpr;ru>
fe;jfk;> elkz;ldk;> gplhyfk;> nry;fz;zp> Kff;fhl;rp> Ml;Fbr;rp>
mhprj;jp> nfsutk;.
tlnkhop :
`hpjhuk;> Nfhje;jk;> `hpe;jpuk;> elkz;ldk;> elnrsugtjk;> fTuk;>
gPjhgk;> fhe;jplzk;.
mugp :
myk;> `hgpyPd;> kypifd;> m[P]uj;.
- Mjhuk; - mDNghf itj;jpa etePjk; ghfk; 6.
11
jkpopy; :
kle;ij> ehup> Njtp> jpUkle;ij> ngz;bh;> tho;kle;ij Njtp>
klyhp> tsh;kle;ij.
- ,uhkNjth; rpj;j kUj;Jt fsQ;rpak; gf;fk; 32.
jhsfj;jpd; cw;gj;jp
“Mnkd;w jhsfj;jpd; gpwtp NfS
Mj;jhs;jhd; Njtfq;if jd;dpy; jhDk;
thnkd;w kz;nzLj;J jhsk; NghNy
tifahfg; gpbj;JNk jhd; jhsq;nfhl;b
Xnkd;w Gth;Nyhfj;J vwpe;J Nghl
cUz;L NkNy fe;jfe; jhd; tpisAk; g+kp
jhndd;w jDf;Fs;Ns tPo;fj;jhDk;
jhsfe;jhd; cw;gj;jp ahd thNw”.
- Nghfh; 7000 %d;whtJ fhz;lk;
gQ;rg+jf; $WghL :
 gr;ir ntl;L gjpdhW> ee;jPrh; fiy Qhdk;> ,uthj rpfpr;rh
Mfpa E}y;fspy; mhpjhuj;ij gpUj;tp $whfTk;
 Nghfh; fhu rhu Jiwapy; - NjA $whfTk;
 mg;Jy;yh rhapG mDNghf itj;jpa etePjk; vd;w E}ypy;
gpUjptp +mg;G + NjA $whf tpthpj;J cs;shh;.
“rPug;gh jhsfKe; jhuq; fe;jp
rpiytPu kpite;Je; jPajhNk”
vDk; Nghfh; fhurhu Jiw ghly; thpfshy; mhpjhuj;jpd;
gpUjptpapd; mk;rKk;> mg;Gtpd; mk;rKk; ,jpy; mjpfkhf ,Ug;gjhYk;>
NjAtpd; mk;rk; Fiwthf ,Ug;gjhYk; ,J Fiwe;j #l;by; vhptJ
,y;iy.
12
jhsfj;jpd; tiffs; :
5 tifg;gLk;
1. kz;zhpjhuk;
2. klyhpjhuk;
3. nghd;dhpjhuk;
4. nts;is jhsfk;
5. fWg;G jhsfk;
kz;zhpjhuk; :
kQ;rs; mhpjhuk; vdg; gy ngah;fs; cz;L. ,jpy; kly;fs; ,uhJ.
ngUk;ghYk; kz; fl;bia NghypUf;Fk;. ,J ngUk;ghYk; tz;zj;jpw;Nf
cgNahfg;gLj;jg;gLfpwJ.
kly; mhpjhuk;> nghd;dhpjhuk; :
,e;j ,uz;L tiffspYk; kQ;rs; tz;zKs;s gsgsg;ghd
kly;fs; cs;sd. Mdhy; ,jd; kly;fs; xbj;jhy; xbahky; tisAk;>
,J ,urthjj;jpw;F Vw;wJ.
Nfhje;j jhsfk; (m) nts;is mhpjhuk; :
,J khl;Lg;gy; jhsfk; vd;Wk; miof;fg;gLk;. khl;bd; gy;iyg;
Nghy ntz;zpwk; cs;sjhf ,Uf;Fk;. neUg;gpy; Nghl;lhy; GifahJ.
neUg;gpw;F XlhJ.
fUg;G mhpjhuk; :
,jid rpy kUj;Jth;fs; fUg;G nfe;jfnkdr; nrhy;fpd;whh;fs;.
Mdhy; mry; fUg;Gj; jhsfkhdJ vt;tsT ghypy; Nghl;lhYk; cwpQ;rp
Fbj;J tpLk; rf;jp mjw;Fz;L. fUg;Gf; fe;jfj;;jpy; mt;tpj rf;jp
fhzg;glhJ.
,tw;Ws; Kjd;ikAk;> mjpfk; cgNahfg;glj;jf;fJk;> tUzj;jpy;
nghd;idg; Nghd;Wk;> mg;gpufj;ijg; Nghy kly; klyhAs;sJk;>
gsgsg;Gs;sJkhd kly; mhpjhuk; vd;w nghd;dhpjhuk; MFk;.
13
jhsfj;jpd; nghJf;Fzk; :
“jhsfj;jpd; NgUiuf;fj; jhYfTs; Neha;F\;lk;
ePsf; Fsph;fha;r;ry; ePLfgk; - ehsfq;nfhs;
J\;lg; gwq;fpg;Gz; #oYfz; kz;il Neha;
fpl;lg; gLgkh fpsj;J”.
jhsfj;jpdhy; ehf;F> fghyk; ,itfisg; gw;wpa Neha;> Fsph;Ruk;>
fgk;> %j;jpu ehsj;ijg; gw;wpa gwq;fpg; Gz;> mOfz;> kz;il Neha;
Kjypad ePq;Fk;.
(Fzghlk; jhJ rPt tFg;G – gf; 326)
nra;ifAk; FzKk; :
 Rukfw;wp
 Nfhioafw;wp
 the;jpAz;lhf;fp
 cly; Njw;wp
 cly; cukhf;fp
- msT mjpfg;gl;lhy; tplkpf;Fk;.
- Fzghlk; jhJ rPt tFg;G gf;fk; 328.
 vy;yh tiffSk;> Fl;l Neha;> jhJ el;lk;> Ruk;> fgNeha;
Kjypatw;iw ePf;Fk;.
 vy;yh tif jhsfKk; rijapy; gw;wp mjid mOfr; nra;J
,uzj;ij cz;lhf;Fk;. rq;Nfhrdfhhp FzKilaJ.
,uzj;jpd; Nky; kPjKs;s rijia mopj;JtpLk;. tapw;wpYs;s
Ez;GOf;fis ehrkhf;Fk;.
- mDNghf itj;jpa etePjk; ghfk; - 6
jhsfj;jpd; Fzk; :
jhsfk; vy;yh tif cNyhfq;fisAk; ntl;ilahf;fp rpijj;J
mopj;J tpLk;. ,d;Dk; itj;jpa Kiwfspy; thj Kiwfspy; ,jid
14
Nrh;g;gjpdhy; me;j Nahfq;fisg; gad;gLj;jp mjpf cgNahfj;ijf;
nfhLf;Fk;.
,jpypUe;J nra;ag;gl;l ,urthjg; nghd;dhdJ vy;yh tiffisf;
fhl;bYk; rpwg;Gilajhf ,Uf;Fk;.
,jpYs;s tq;fj;ij vLj;J jq;fj;Jld; Nrh;j;J nre;J}hpj;J thjk;>
itj;jpak; vd ,U Kiwfspy; gad;gLj;Jfpd;wdh;.
- mDNghf itj;jpa etePjk; ghfk; - 6 gf;fk; 69-114.
 jhsf rj;Js;s %ypif tOjp
 jhsf ghlhzj;jpy; tq;fk;> mak; rj;Jf;fs; cs;sd.
- caph;fhf;Fk; rpj;j kUj;Jtk;> gf;fk; 567.
Rj;jp Kiwfs;
jhsfj;ijg; gzk;Nghy; ntl;b> rPiyapy; Kbe;J Nfh%j;jpuk;> fhb>
Rz;zePh;> G+rzpf;fha; ePh;> Mtpd; ghy;> murk;gl;ilf; f\hak;> ,itfs;
xt;nthd;wpYk; jdpj;jdpahf Cwitj;Jj; Njhyhe;jpukhf ePh; Kf;fhy;
ghfk; Rz;Lk; tiu mtpj;J vLf;fr; Rj;jpahk;. xU gyk; jhsfj;jpw;F
xt;nthUgb ePh;g;nghUs; vLj;Jf; nfhs;s Ntz;Lk;.
 xU gyk; (35 fpuhk;) jhsff; fl;bia vLj;J> Rz;zhk;Gf;
fy;ypd; ,ilapy; itj;Jg; gdq;fs;spdhy; 10 Kiwf;Ff;
Fiwahky; jhspj;J vLj;Jf; fOtp cyh;j;jpf; nfhs;sr;
Rj;jpahk;.
 jhsfj;ijr; rd;dkhf ntl;b> ,ul;il kbg;Gr; rPiyapy; fl;bf;
Nfh%j;jpuk;> mhprp fOtpa ePh;> Gspj;j fhb ,itfnshd;wpy;
%d;W ehs; Njhyhe;jpukhf fkyhf;fpdp nfhz;L vhpf;fr;
Rj;jpahk;.
 mKhp (rpWePh;) xU gbapy; (1.3ypl;) Fg;igNkdpr;rhW fhy; gb
(325 kp.ypl;) fw;Rz;zk; fhy;gb (325 kp.ypl;) fye;J> mLg;Ngw;wpj;
15
jhsfj;ijf; fpopfl;bj; Njhyhe;jpukhf vhpj;J vLj;Jf; nfhs;sr;
Rj;jpahk;.
 jhsfj;ijf; fw;Rz;zj;jpypl;Lf; fOij ePhpl;Lj; jhspj;J
vLj;jhYk; Rj;jpahk;.
jhsfk; nfhz;L nra;ag;gLk; kUe;Jfs;
mhpjhug; nghb :
mhpjhuk; (fl;b)
mhpjhuk; fl;bia Rz;zhk;gpy; Ntf itj;J vLf;fTk;.
msT : 300 fpuhk;> 5 Ntis> fhiy> khiy
mDghdk; : Njd;
jPUk; Neha; : vypf;fbtplk; jPUk;.
- rpj;j kUj;Jt ifKiw itj;jpak;> gf;fk; 138.
jhsf khj;jpiu :
msT :  Njdpy; ,ioj;J XhpU Jsp fz;zpy; tplTk;.
jPUk; Neha; :  tple;jPz;ly; jPUk;.
- rpj;j kUj;Jt ifKiw itj;jpak;> gf;fk; 29.
jhsfr; Rz;zk; :
msT : 5 Kjy; 10 kp.fp
jPUk; Neha; :  rpwg;ghf fgg; gpzpfs; jPUk;. rsp> Rthrk;> fhrk;>
uj;jfhrk; jPUk;.
- rpj;j kUj;Jt ifKiw itj;jpak;> gf;fk; 116.
mupjhug; Gif :
,Uky; Neha; jPUk;.
NrUk; ruf;Ffs; : jhsfk;> Njd;nkOF.
-  mDNghf itj;jpa etePjk; ghfk; 6.
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mupjhuk; NrUk; gpw kUe;Jfs; :
,urg;Gif :
msT : Gifia %f;fpd; topahf cs;spOf;fTk;.
Jiz kUe;J : Ntg;ngz;nza;
jPUk; Neha; : tple;jPz;b kaf;fkhdtd; tpopg;ghd;
- rpj;j kUj;Jt ifKiw itj;jpak;> gf;fk; 135.
nfUl mQ;rdk;
jhsfk;
,urk;
,e;Jg;G
ngUq;fhak;
,itfis msthf vLj;J Nga;g;gPh;f;fpiy rhw;why; Ml;b khj;jpiu
nra;J gzntil ntw;wpiy rhw;wpy; kj;jpj;J fz;zpypl m\;lehfk;
KjyhAs;s rh;t tplk; jPUk;.
- tpl itj;jpa rpe;jhkzp gf;fk; 70
jhsff; fUg;G :
1 Kjy; 2 cSe;njil
(65 kp.fp) (130 kp.fp)
JizkUe;J :
Njd;> nea;> jhsprhjp #uzk;.
jPUk; Neha; :
fhrk;> Rthrfhrk;> <is> Ruk;.
- Fzghlk; jhJ rPt tFg;G gf;fk; 253
,yFthf;fpdp Fkhud;
msT : Fd;wpasT
jPUk; Neha; : rd;dp> Ruk;.
17
THETRAN KOTTAI
18
Njw;whd; nfhl;il
NtW ngah; : ,y;yk;> fjfk;> rpy;yk;> NjW
(Fzghlk; %ypif gf;fk; 549)
Eng - Clearing nut tree
Tel - Chilla - Chetty
Mai - Thetta - maram
Kan - Chali - Mara
Suns - Katuka
Hindi - Nirmali
Pers - Chilbinj
Fzghlk; %ypif gf;fk; 549
Tel - Katakumu
Mai - Katakam
Sans - Kataka
Glossary of Indian Medicinal Plants
R.N.Chopra, Nayar, IC Chopra Page.236
Tarn - Tetran-kottai
Eng - Clearing nut
Beng - Indiga
Can - Chillibij
Materia Medica of India & their therapeutics
Rustomjee, Nanabhai Page : 408
19
Tamil - Akolam, Illalam, Kadali, Sillam, Tetta, Tettankottai
Bengal - Nirmali
Bombay - Gajrah, Nirmal
Hindi - Neimal, Nelmal
Mala - Tettamparel
Urdu - Nirmali
Tel - Andugu, Indigu
Indian Medicinal Plants – Kirtikar & Basu 1649
tshpay;G : kuk;
,k;kuk; gh;kh> tq;fhsk;> njd;,e;jpah Kjypa ehLfspy; tsh;fpwJ.
gad;gLk; cWg;G : gok;> tpij
Fzk;
Rit - ifg;G
jd;ik - ntg;gk;
gphpT - fhh;g;G
nra;if
clw;Nww;wp - Alternative
cukhf;fp - Tonic
grpj;J}z;b - Stomachic
cs;soyhw;wp - Demulcent
rpWNfhioafw;wp - Mild Expectorant
Fzghlk; %ypif tFg;G gf;fk; : 549
Alternative
Tonic
Stomachic
Demulcent
Materia Medica of India & their therapeutics Page : 409
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nghJFzk; :
XJU Njw;W tpj;jp DWRig kJujpf;fe;
jPjW f\haQ; rPje; jpfo;Fzq; FUNt ahFk;
VJkpy; kJuk; ghfkpay; ntl;il Nkfk; jhfk;
NkhJW jhgj;NjhL %j;jpu fpUr;ruk; %yk; (206)
Njw;whq;nfhl;il jpf;j> f\ha> kJu RitfisAk;>
rPjtPh;aj;ijAk;> FU Fzj;ijAk;> kJutpghfj;ijAk; nfhz;lJ. ntl;il>
Nkfk;> jhfk;> %j;jpufpUr;rpuk;> %yk; Kjypaitfis Nghf;Fk;.
- gjhh;j;j gQ;r Fz kQ;rhp> gf;fk; 226.
gpukpnts;is ntg;Ggrp Nguuh fLg;Ngh
nlhpfphpr; ruk;Gz;Z kpd;whk; - tUke;je;
Njw;whq; nfhl;ilf;/Njh jPl;l kUe;jhFq;
$w;wq;fz; khNkeP nfhs;
- gjhh;j;j Fzghlk; - 848
Njw;whd; nfhl;ilf;F gpuNkfk;> ntl;il> cl;#L> tapw;Wf; fLg;G>
%j;jpu vhpr;ry;> %j;jpuf; fLg;G> uzk; ePq;Fk;.
$w;nwd; Eiwf;Ftpopf; NfhksNk! vg;NghJk;
Cw;whk; gpukpaKk; cl;Gz;Zk; Mw;wtpyhy;
ntl;il mff;fLg;Gk; tPwp thpw;Nww;whq;
nfhl;iljid ePnaLj;Jf; nfhs;
- Fzghlk; %ypif gf;fk; 549
Njw;whk; tpijaJjhd; jPgdj;ijg; Nghf;Fkdy;
Mw;WkpF fz;Zf;fU kUe;jhk; - $w;wh
apUe;Jq; fphpr;ruj;ij vq;Fkpyh Njhl;Lq;
FUj;Jt Kz;lhf;Fq; Fwp.
- Fzghlk; %ypif gf;fk; 550
21
tpijapdhy; nts;is> ntl;il> cl;#L> kpFgrp> tapw;Wf; fLg;G>
rpWePh;> vhpr;ry;> Gz; Mfpait ePq;Fk;. ke;jk; cz;lhFk;. ,J fz;Zf;F
ed;kUe;jhFk;.
Rj;jp Kiw
Njw;whd; nfhl;iliag; gRtpd; ghypy; 3 kzpNeuk; Cwg;Nghl;L
ePhpy; fOtp cyh;j;jpf; nfhs;sTk;. mjd; vilf;F ehY gq;F rpWfPiur;
rhw;iw tpl;L miug;ghfk; Rz;l vhpj;J> ePhpy; fOtp vLf;fj;
J}a;ikahFk;.
Fzghlk; - %ypif tFg;G – 550 (Kjy; ghfk;)
Mjhug; gFjp : Strychnos Potatorum, Linn.
Power of the seed is given internally with milk in irritation of the urinary organs
and in gonnorrhoea. It is also used as a remedy in diabetes.
- Indian Materia Medica Page 182. Dr. K.M. Nadkarni (Vol. I)
Njw;whd; tpij
,ijg; nghbj;J ghypy; fye;J cs;Sf;Ff; nfhLf;f ePh;RUf;F>
ntl;il Kjypad jPUk;. ePuoptpw;Ff; nfhLf;fyhk;.
- Fzghlk; - %ypif tFg;G gf;fk; vz; : 550
Njw;whd; tpijapd; kUj;Jtg; gad;fs;
,ij jz;zPhpy; ciuj;J fiuj;jhy;> mj;jz;zPh; njspe;J epw;Fk;.
,j;Jld; fw;g+uQ;Nrh;j;Jj; Njd;tpl;L miuj;J nkOfhfr; nra;J
fz;zpy; Nghl;Ltu fz;zpy; gPis js;sy;> ePH;tbjy; Mfpait NghFk;.
,j;Jld; ,e;Jg;igr; Nrh;j;jiuj;Jf; fz;zpypl fz; rptj;jy;
ePq;Fk;. ,jd; nghbia Njdpw; fye;J fl;bfspd; kPJ g+rptu> fl;bfs;
rPf;fpuk; gOj;J cilAk;. ePhpy; fye;J jpdk; ,UNtis cl;nfhz;L tu
khh;Gr;rsp> Nfhiof;fl;L ,sfp ntspg;gLk;.
22
rpwpa mstpy; Foe;ijfSf;Ff; nfhLj;J tuyhk;.
‘Njw;whd; nfhl;ilapl;L Njw;W ike;jiu’ vDk; Nkw;Nfhshy; mwpf.
Njw;whd; tpij NrUk; ePuoptpw;fhd kUe;Jfs;
Njw;whdpd; tpj;J ehyiuahq; fhR
jpuz;ltj;jpf;fha;g;nghb Akpuz;L fhR
Neh;j;jpaha; ntz;Fd;wp Kisiag; Nghf;fp
eph;zakha; fhrpuz;L %d;We;jhNd
rhw;whtpd; Nkhhpyiuj;Nj fyf;fpj;
jg;ghkw; Nwd;Fj;jp kz;lyq;nfhs;
Nghw;W rptfpUigahy; ePuopT jPUk;
- Nkf epthuz Nghjpdp> g. vz;. 9
Njw;whd; tpij gpuNahfk;
Njw;whd; nfhl;il rPty; tpuhfndil 2¼ (9.5 fpuhk;) cyh;j;jp
,bj;J mj;jpg; nghb tWj;Jilj;J> Njhy; Kis Mfpaitfs; ePf;fg;gl;l
nts;isf; Fd;wpkzpgUg;G> ,it tiff;F tuhfndil xd;W> ,tw;iw
gRtpd; Nkhhpy; xU ehs; Cwitj;J kWehs; mk;kpapy; tuhfndil Njd;
fye;J ghlQ;nra;aTk;. ,t;tpjk; 1 jlit 40 ehs; nra;a ePuopT jPUk;.
- Nkf epthuz Nghjpdp – g. vz;. 163.
kUjk;gl;il f\hak;
kUjk;gl;il f\hae;jhndhd;W
tUe;Jiuj;Jf; Nfs; kUjk;gl;il jhDe;
jphpgit tpyhrkpr;R ehtw;gl;il
Njw;whd; tpj;Jf; Nfhiuf;fpoq;fpNdhNl
ey;Njdpw; fhrpilAq; Fj;jp nfhs;S
euDf;F tUe; jhgePuopT jPUk;
- Nkf epthuz Ngjpdp> g. vz;. 9
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Nkf Neha;f;F #uzk;
ehty;tpij gUg;G> tpshkpr;ir Nth;> ntl;bNth;> ,ytq;fk;>
mf;fufhuk;> nfhd;iwg;g+> Mthuk;g+> Njw;whd;nfhl;il> rpWFwpQ;rhd;
r%yk;> rPe;jpy; rh;f;fiu ,it tiff;F 100 fpuhk; vLj;J jdpj;jdpNa
,bj;Jj; J}shf;fp xd;W Nrh;j;J tbfl;b itj;Jf; nfhs;sTk;.
msT : Njf;fuz;b
fhiy> khiy ,UNtis
jPUk; Neha; : kJNkfk;> Nkfk;
- ruNge;jpuh; rpj;j kUj;Jtr; Rlh;> g.vz;. 195
Mthiuahjp tpOJ
Mthiuahjp ePuopitg; Nghf;F
khtiuf; nfhOe;J eWtpypf;nfhOe;J
ehthY Kiutplj;Nj hpd; nfhOe;J
ew;fl;Lf; nfhbapdpiy Njw;whd;nfhl;il
Nkthj ePh;r;Rz;b ghiyNah ehDk;
tpOjiuj;Jg; goj;jsthnaLj;J
tpOjiuj;Jg; goj;jsthnaLj;J
ehSk; ththntd; nwUikj; japhpdpNynfhs;s
tYj;jJTe; jPUk; tpoTiuj;j jhNk.
Mthiu tpij #uzk;
Njw;whd; tpijfLf;fha; nrg;ghpa ththiu
Nkw;Nwhy; tpsk;gprpD kpjj;id Aq;Nfhw;nwhb eP
gq;nfhd;W fhyha;g; gRtpd;Nkhhpw;gUfg;
nghq;fptUk; ePuopT Nghk;
- Nkf epthuz Nghjpdp – g.vz;. 49
Njw;whd;nfhl;ilj; ijyk;
msT – fhnril (fhiy> khiy ,UNtis)
24
jPUk; Neha;fs;
,j;ijyj;ij cs;Sf;Fr; rhg;gpl;lhYk;> Nky; KOtJk; g+rpj;J
J}thiyapdhy; gpbj;jhYk; ehd;F ehl;fSf;nfhU Kiw jiyKOfp
te;jhYk;> Nkf moiy> Nkf ntl;il> Nkf ePh; Kjypa gw;gy
Nkfrk;ge;jkhd Neha;fs; FzkhFk;.
- ruNge;jpuh; rpj;j kUj;Jtr; Rlh;> g.vz;. 497
Njw;whq;nfhl;il nea;
Njw;whq;nfhl;il – 500 fpuhk;
rPufk;> rhjpf;fha;> rhjpgj;jphp> fpuhk;G> rpWehfg;g+> jhsprgj;jphp>
mjpkJuk;> thYSit mhprp> fUQ;rPufk;> Vyhprp> Ntq;ifg;gl;il>
rjFg;ig> Rf;F ,it tiff;F 25 fpuhk;
rh;f;fiu - 500 fpuhk;
gRntz;nza; - 1000 fpuhk;
Kjypy; Njw;whq;nfhl;iliaj; jz;zPhpy; Cwitj;J fOtp vLj;J
cyh;j;jp gRk;ghypy; 3 ehs; Cw itj;J vLj;J gpd;dh; gRk;ghiy Cw;wp
ed;F nefpo miuj;J miuj;j tpOJld; ntz;iziar; Nrh;j;J
nghd;dpwkhFk; tiu fha;r;rp kw;w ruf;Ffis ,bj;J tbfl;ba
#uzj;ijAk;> rh;f;fiuiaAk; fye;J fpz;b vLj;J itj;Jf; nfhs;sTk;.
msT : xU Njf;fuz;b (4 kp.yp) ,UNtis
jPUk; Neha;fs;
gpj;j ntl;il> if fhy; vhpT> ,Uky;> cly;#L> ePh;f;fLg;G>
Nkffhq;if> nts;is> ntl;il> %ytpahjp Kjypad jPUk;.
gj;jpak; : Gsp ePf;fp czT cl;nfhs;sTk;.
- ruNge;jpuh; rpj;j kUj;Jtr;Rlh;> g.vz;. 619
25
Nrhk> Nuhf Neha;fSf;F kUe;J
- mf];jpah; itj;jpa rjfk;> g.vz;. 28
Njw;whd; tpij FbePh;
Njw;whd; tpiufLf;fha; nrg;ghpa ththiu
Naw;w tpsk;gprpNdh bj;jidAq; Nfhw;nwhbaha;
gq;fh aWfhw; gRtpd;Nkh hpw;gUfg;
nghq;fp tUePuopT Nghk;.
Njw;whd;tpij> fLf;fha;> Mthiu> tpshk;gprpd; ,it ehd;ifAk;
Xnuilahf vLj;J> gRtpd; Nkhhpy; fye;J xU ehisf;F MWKiw
gUfptu ePuopT ePq;Fk;.
- Fzghlk; - %ypif> g.vz;. 551
kUjk;gl;ilf;f\hak;
fhiy – khiy ,U Ntis
- mfj;jpah; ,uz;lhapuk; ghfk; 3> g. vz;. 3
mKjty;yp ijyk;
- mfj;jpah; ,uz;lhapuk; ghfk; 3> g. vz;. 8
rpNyj;Jk;> thj ePuopTf;F kUe;J
mhpjhuk;> kNdhrpiy> nts;isf;Fq;fpypak;> tpshk;gprpd;> Njw;whd;
tpij> ujk; ,itfis rkdha; nghbj;Jj; Jzpapy; fpopfl;b 3 Kiw
gr;rhprpf; fOTePhpy; Cwitj;J cyh;j;jp fhbtpl;liuj;Jf; Fd;wpasT
khj;jpiuahf;fp KUq;if ,iyr;rhw;wpy; cz;z kJNkfk; jPUk;.
- caph;fhf;Fk; rpj;j kUj;Jtk;> g.vz;. 367
26
rpNyj;k gpuNkfj;jpw;F kUe;J
MthiuNth;gl;il> Ntk;G> kUJ> Ntq;if> flyopQ;rpy; ,itfspd;
gl;il> KUq;if tpj;J> jphpgiy> Kj;jf;fhR> Njw;whd;nfhl;il
,itfisf; FbePhpypl;L NjDld; cl;nfhs;s rpNyj;k gpuNkfk; jPUk;.
- caph;fhf;Fk; rpj;j kUj;Jtk;> g. vz;. 367
NkfNehahspapd; jhfj;jpw;F kUe;J
Mthiu> epyg;gid fpoq;F> ePh;g;g+yh> Kj;jf;fhR> tpy;tNth;>
Njw;whd; tpij> nghd;KRl;il> fUQ;#iu> Rz;ilNth;> ,ye;ij Nth;>
NghPr;R> khJis Nth;> new;nghhp> rPdhfw;fz;L> nts;shp Nth; tiff;F
xU foQ;R (5.1 fpuhk;) ,bj;J ,uz;L gb ePhpy; Nghl;L 1/8 tw;w itj;J
cl;nfhs;s Neha; jPUk;.
- caph; fhf;Fk; rpj;j kUj;Jtk;> g. vz;. 371
fgpj;jeph;ahr fpahok;
tpshk;gprpd;> kuhl;bnkhf;F> Nfhiuf;fpoq;F> gUj;jp tpij>
Fd;wpNth;> Njw;whd;nfhl;il> kukQ;rs;> guq;fpr; rf;if> Gspaq;nfhl;il
,itfis rk vil fpahok; itj;J mj;Jld; Njd; fye;J rhg;gpl;lhy;
rfy Nkfq;fs; epth;j;jpahFk;.
- mDgt itj;jpa Njt ufrpak;> gf;fk; 510
Njw;whd; tpijg; gpuNahfk;
Njw;whd; tpijia rPtp Cwitj;jiuj;j tpOJ gyk; 1/4 (10.2
fpuhk;) ,jid 1 gyk; (4 fpuhk;) gRntz;izapy; Fioj;Jf; nfhs;f.
,t;tpjk; 2 NtisAk; 5 ehl;fs; rhg;gpl Nkf xOf;F jPUk;.
- ePuopT Neha; kUj;Jtk;> gf;fk; 187
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Njw;whd; cz;il
msT : tuhfndil (4.2 fpuhk;)
fhiy khiy 1 khj;jpiu
- Nkfepthuz Nghjpdp gf;fk;> 182
Njw;whd;tpij NrUk; gpw Neha;fSf;fhd kUe;Jfs;
Njw;whq;nfhl;il Nyfpak;
rhe;jkhkpd;dnkhU Nyfpaq;fs; rkh;j;jhd gyike;J
Njw;whq;nfhl;il Nrh;e;jnjhU jphpfLF jphpgyhjp rpw;wuj;ij rPufk;
tdf;fiu gye;jhd; ghe;jkha;g;nghb nra;J itj;Jf; nfhz;L gQ;rjhiu
gyk; ehYgbahtpd; ghy;> Njha;e;jplNt fyf;fpaij ehfgw;gk; $l;bj;
jpd;W> miuapNyapUNtis ,UgJehs; nfhs;S mg;gNd %yNdh
afYQ; nrhd;Ndhk;> ,suNt raKlNdh aj;jpRuthjkpjkhd mf;fpdp
ahke;jk;NghNkh.
- mf];jpah; ghpg+uzk;
Njw;whq;nfhl;il Nyfpak;
Njw;whd;tpij 500 fpuhk;
,ijj;jz;zPhpy; xU ehs; Cwitj;J ed;F Nja;j;Jf; fOtp Nky;
Njhiyg; Nghf;fpf; fhaitj;J ,jDld;>
jphpfLF tiff;F - 70 fpuhk;
jphpgyh tiff;F - 70 fpuhk;
muj;ij - 70 fpuhk;
rPufk; - 70 fpuhk;
mKf;fuh fpoq;F - 70 fpuhk;
- ,tw;iw #uzpe;J gRk;ghypy; (4 ypl;lh;) gidnty;yj;ij
(1 fpNyh) fiuj;J tbfl;b rl;bapypl;L mLg;gpNyw;wp ghFgjj;jpy;
#uzj;ij Nrh;j;J gUtj;jpy; Nghjpa msT Njd;> nea; ,uz;Lk; Nrh;j;J
fpz;b gj;jpug;gLj;jTk;.
28
msT – fow;rpf;fhasT (,U Ntis)
mDghdk; - ehfgw;gk; 1/2 Fd;wpAld; (65 kp.fp) 48 ehl;fs;
cl;nfhs;s %yNeha; FzkhFk;.
- ruNge;jpuh; rpj;j kUj;Jtr;Rlh;
Njw;whd; fw;gk;
Njw;whd; tpijia cyh;j;jp ,bj;J rypj;J itj;Jz;zTk;.
- mfj;jpah; ml;ltiz thflk;> g. vz;. 30
gpukpak; jPu nghb
Njw;whd; tpijAld;> rPufk;> jz;zPh;tpl;lhd; fpoq;if nghbj;J
gRntz;izapy; %d;W ehl;fs; ju gpukpak; jPUk;.
- mfj;jpah; ml;ltiz thflk;> g. vz;. 130
ngUk;ghl;L jPu kUe;J
Njw;whd;tpijia miuj;J ,uz;L thiog;goj;jpy; %d;W ehl;fs;
mUe;j ngUk;ghL ePq;Fk;.
- mfj;jpah; ml;ltiz thflk;> g. vz;. 132
Njhlk; jPuf;Fok;G
Njw;whd;tpij 1 tuhfd; (4.2 fpuhk;)> jpg;gpyp 1 tuhfd; (4.2 fpuhk;)>
gr;ir fw;g+uk; 1/2 thufid (2.1 fpuhk;) nfhk;G Njdpy; ,ioj;J ehtpy;
jlt midj;J NjhlKk; ePq;Fk;.
- mfj;jpah; ml;ltiz thflk;> g. vz;. 169
it#hpf;F kUe;J
Njw;whd; tpj;J> Nfhiuf;fpoq;F ,uz;ilAk; eRf;fpg; Nghl;L
jz;zPh; vLj;J mjDld; NfhNuhridiaf; $l;b rpwpJ rPufk; Nrh;j;J
cs;Sf;F rhg;gpl it#hp FzkhFk;.
- ePuoptpw;F kUj;Jtk;> g.vz;. 440
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ngUk;ghL jPu kUe;J
ghYk; ngUk;ghL ghuKld; te;jhy;
MWe; Njw;whd; tpijaiuj;J
$Wk; gjf;Fld; tpl;Lg; ghpTld;
Fbj;Jg; ghub Qhdg;ngz;Nz
Njw;whd;tpijia ePhpypl;L miuj;Jf; fiuj;J Fbf;f ngUk;ghL
jPUk;.
- jdte;jphp itj;jpaf;Fk;kp> 300 gf;fk; 95
<isf;F
ntz;ik epwj;jpy; cUz;il tbtKs;s ,jd; nfhl;iliag;ghypy;
Cwitj;J miuj;Jg; ghYld; cl;nfhs;s gpj;jfhrk;> <is ePq;fp
fharpj;jpahk;.
- Nghfh;kiy thflk;> gf;fk; 51
30
THURUSU
31
JUR
JUR vd;wiof;fg;gLk; kapy; Jj;jkhdJ cgurr; ruf;Ffspy;
xd;whf Nghfh; fhurhuj;Jiw tifg;gLj;Jfpd;wJ.
Fzg;ghl tifapy; cgurr; ruf;Ffs; 121 vd;Wk;
tifg;gLj;jg;gl;Ls;sJ.
,jid
jhsg;gh cgurk; E}w;wpUgjhFk;.
vd Nghfh; fhurhuj;Jiw $WfpwJ.
,e;j cgurr; ruf;Ffspy; JUrhdJ fhe;jk;> mg;gpufk; ,tw;wpw;F
mLj;jg;gbahf 3 tjhf itf;fg;gl;Ls;sJ.
,j;jifa JUrhdJ ,aw;ifapYk; fpilg;gJ vd;Wk;> rhjhuzkhf
nraw;ifapy; nrk;Gld; fe;jf jpuhtfk; $lf; fha;r;rp vLj;J cg;ghf;fpf;
nfhs;syhk;.
,J ,t;thW ,Uf;f mNj Nghfh; 7000 vd;w E}ypd; JUfhdJ
itg;Gg; ghlhzj;jpy; itj;Jr; nrhy;yg;gl;Ls;sJ.  ,jid
JUR: NtWngah;fs;
JUR nghJthf kapy; Jj;jk;> fz;lH> ew;gr;ir vd;w
ngah;fspdhy; toq;fg;gLfpd;wJ vd;W Fzg;ghlk; jhJ tFg;G
$Wfpd;wJ.
Nghfh; epfz;L ml;ltiz gf;fk; 7y; RliyNahd> epwKj;jd;>
ep\;fsd;> fq;fhsd; MLq;$j;jd; eyg;gr;ir MjpFUehjd;> khy;kr;rpdd;
ke;jhuhfq;ifNahd; guRghzp> fUNkfd; gy;Yf;Nfj;jhd;> fLq;$j;jd;>
fhrhk;GJHzj;Njhd;> $j;jd;> FiyNahd;> Fd;iwtpy;yp> fz;lh;>
Mjr;rj;JU> fz;Zf;Furd; vd;W $wg;gl;Ls;sJ.
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rl;lKdp jd;Dila epfz;L vd;Dk; E}ypy; fz;lh;> ePyg;ghzp>
ew;gr;ir> fUNkfd;> FUehjd;> ePyf;fs;sp> Myg;gilNahdhjp>
fliyNahd; vd;w NtWngah;fshy; JUrpid Fwpg;gpLfpd;whH.
Rit: Jth;g;Gld; ntFl;lyhapUf;Fk;
gphpT:
fhHg;G
tPhpak;:
ntg;g tPhpak;
vy;yhg; nghUl;fSk; G+jkakhdJ vd;gJ ntspg;gil rpj;jh;fs;
nghJthf ruf;Ffis Ritapd; mbg;gilapy; jhd; G+j $Wghl;il
tFj;jpUf;fpd;whHfs;.
Jhprpd; Rit Jth;g;G vd;gjhy; Jth;g;G = kz; + fhw;W vdNt
JUrhdJ gpUjptp> thA G+jj;ij mbg;gilahff; nfhz;lJ vd;gJ njhpa
tUfpd;wJ.
vdNt JUrpd; Fzk; vd;d vd;W MuhAk; NghJ mJ kz; kw;Wk;
fhw;W G+jq;fspd; ,aw;if Fzj;ijNa ngWk; vd;Wk; ehk; mwpayhk;.
JUrpd; gz;Gfs;:
1. ,J ePy epwkhf ,Uf;Fk;
2. ,jidg; nghbf;f gr;irahf ,Uf;Fk;
3. ,J ePhpy; fiuaf;$baJ.
4. Jhprpid jPapypl;lhy; JhprpYs;s ePH ePq;fp gr;irAk;
ntz;ikAk; fye;j rhayhFk;.
5. jP mjpfkhdhy; mjpypUf;Fk; jpuhtfk; ePq;fp jhkpu th;z
J}s;fshFk;.
6. ,jw;F xUtpj Jth;g;Gk; ntFl;lYk; cz;L.
7. JhpR fiuj;j ePH ePy epwkhapUf;Fk;.
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Fzg;ghlk; jhJrPt tFg;G E}ypy; gf;fk; 415y; rTl;Lg;G> njhl;bg;
ghlhzk;> mQ;rdf;fy;> ntbAg;G> #ld;> mg;gpufk;> rPdk;>
nts;isg;ghlhzk; fy;Y}g;G> kpUjhH rp;q;fp> ,e;Jg;G> ehfk;> tq;fk;>
rTf;fhuk; Kjypad gifahFk.
mhpjhuk;> etr;rhuk;> ntq;fhuk;> tPuk;> fe;jp> #jk;> G+uk;> rpiy>
nfshp> epkpis> ,ypq;fk; Kjypad el;ghFk; vd;W $wg;gl;Ls;sJ.
The following are the main points which are helpful to give us some
valuable information regarding Thurusu
1. Source
2. Appearance
3. Methods of Purification of Thurusu
4. Gunam and Action of Thurusu
JUR fpilf;Fk; tpjk;
APPEARENCE
The crystaline salt is blue in colour.  It is also known as Blue Vitriol.
JhprhdJ kapypdJ fOj;jpd; tz;zkha; ,Ug;gjhy; ,J kapy;
Jj;jk; vd;w ngauhy; miof;fg;gLfpd;wJ.  ,jid nghbj;jhy; ,J
gr;ir epwkhf ,Uf;Fk;.
JUrpd; Rj;jp Kiwfs;
JUrpid Rj;jp nra;ahky; mf kUe;jhf gad;gLj;Jk; NghJ eQ;Rf;
FwpFzq;fis Vw;gLj;Jk; vdNt JUrpid Rj;jp nra;J gad;gLj;j
Ntz;Lk;.
1. kapy; Jj;jj;ij td; gRtpd; jd; japuhy;
kapy; Jj;jj;ijg; gRtpd; japhpy; miuj;J milahfj; jl;b Xl;by;
itj;J %b xU Glkpl;L vLf;f Rj;jpahFk;.
- (mfj;jpah; itj;jpa rpe;jhkzp)
34
2. Njitahd Jhprpid nte;ePhpy; fiuj;J tbfl;b Rz;lf; fha;r;rp
cg;Gf; fl;bdTld; vLj;Jf; nfhs;sTk;.
3. JUrpw;F NjDk; nea;Ak; tpl;liuj;J %irapypl;Lf; fha;r;rp
gpwF ghy; Khpj;J tbfl;ba ePhpy; 3 ehs; Cw itj;J cyh;j;jp vLj;Jf;
nfhs;s Ntz;Lk;.  ,q;fdk; Rj;jp nra;j JUR tplf; Fzkpd;wp ,Uf;Fk;.
the;jpia cz;L gz;zhJ.
4. gRtpd; ePhpy; Jhprpid itj;J vhpj;J fOtpnaLj;J nta;apypy;
cyh;j;jpf; nfhs;sr; Rj;jpahFk;.
5. ntz;ikahFk;gb nghhpj;J vLj;jhYk; Rj;jpahFk;.
(Fzg;ghlk; jhJ [Pt tFg;G)
6. fw;whsQ; NrhW nty;yq; fhWk;gh nda;jhd; tpl;L
kw;wij atpj;jhw; Rj;jp kapy;Jj;jk; Mtpd; Nkhhpy;
cw;wpl T+witj;jhw; Rj;jpah Kah; ntz;Lj;jk;
nrhw;Rz; zhg;GePyp Y}wplr; Rj;jp ahNk mkph;jrhfuk;
gjhHj;j #lhkzp gf;fk; 54 Kjw;gjpg;G
7. JUrpid nfhbNtyp rhW rhWtpl;L 3 ehs;
 ntspapy; itj;J vLf;f nts;isaha; Rj;jpahFk;
- ruNge;jpuh; Fd;kNuhf rpfpl;ir Kiwfs; gf;fk; 270
8. nrhy;Yfpw JURjd;id thq;fpte;J
JUir thq;fp japhpY}wg;Nghl;L vLj;J nfhQ;rk; japh;tpl;liuj;J
tpy;iy  jl;b itj;Jf; nfhz;L Xl;il mLg;gpNyw;wp me;j Xl;by; JUR
tpy;iyiag; Nghl;L gpul;b vLj;J itf;f Rj;jpahFk;.
9. ,ak;gpzgr; irj;JUir thq;fpte;J
,ay;ghf gRq;Nfh kaj;jpw;Nghl;L
eak;glNt nahpj;njLf;fr; Rj;jpahr;R
- ahf;NfhG itj;jpak;-300 gf;fk; 110
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gr;irj;JUir thq;fp gRq;Nfhkaj;jpy; Nghl;L mLg;Ngw;wp
vhpj;njLf;fr; Rj;jpahFk;.
10.“JUR Nfhkpaj;jp xU dhNyANyhf tpNghlR”
-jd;te;jphp Xuz;lj;ijyk; gf;fk;22
tpsf;fk;:
Njitahd JUR Jz;ilg; gRtpd; Nfhkpaj;jpy; xU Cw itj;J
vLj;Jf;nfhz;lhy; Rj;jpahFk;.
11. japhpy; xU rhkk; JUir Cwitj;J vLj;Jf;nfhz;lhy; JUR
Rj;jpahFk;.
12.JUirj; japhpy; miuj;Jf; fUfitj;j Xl;by; Nghl;L gpul;b
vLj;Jf;nfhz;lhYk; Rj;jpahFk;.
The stuff abtained from the bazar is usually impure.  It may be purified by
dissolving in-water and crystalizing and for internal  use.  It is purified by being
rubbed with honey and / or ghee and exposed to heat in a crucible.  it is then
soaked for three days in milk or water and dried in the sunlight copper sulphate.
Thus prepared will be free form toxic effect and will not produce vomitting.
- The Indian Materia Medica Dr. K.M. Nadkarni
Jhprpd; nghJFzk; kw;Wk; nra;if
nghJFzk;:
“Gz;zhw;Wq; fhkpaj;jpd; Gz;zhw;Wq; fz;Nzhia
tpz;Nzw;W Kj;JNjhL tPwlf;FQ; - rz;Zfpd;w
the;jpnahL Ngjp jUk; tha;Neha; Rue;jzpf;Fq;
fhe;jp jUe;Jhprp fhz;”.
JUR thjhjp Njh\ tpuzk;> mt ke;j Fa;a tpuzk;> fz;Nzha;>
jphpNjhlk;> rpNy\;k Kfghfk;> thj rPj Ruk; ,tw;iw ePf;Fk;. tkdk;>
tpNurdk;> Nj[R ,itfisAz;lhf;Fk;.
- gjhHj;j Fztpsf;fk;
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nra;if:
cly; cukhf;fp - Tonic
the;jpAz;lhf;fp - emetic
mOfyfw;wp - Antiseptic
Gz;Zz;lhf;fp - caustic
Jth;g;gp - Astringent
rpwpa mstpy; Jhprpid nfhLf;f (1 Kjy; 2 cSe;njil
nfhLf;f) gyfhhp –Tonic rq;furdfhhp -Astringent
mjpf mstpy; nfhLf;f (5 Kjy; 10 cSe;njil) the;jpAz;lhf;fp
(Emetic) Gz;Zz;lhf;fp (caustic)Mf nray;gLk;.
- gjhHj;j Fztpsf;fk;
(jhJ [Pt tpsf;fk; - fz;Zrhkpak;)
JUR NrUk; gpw kUe;Jfs;
Jthjr nre;J}uk; - fj;jpah; itj;jpa gps;is jkpo; gf;fk; 7
JUR FU - jpU%yh; fUf;fpil itj;jpak; gf;fk; 111
JUR FU - NghfKdpth; 7000 f;F #];jpuk; 700 gf;fk; 37
JUR Rz;zk; - jd;te;jphp fiyQhdk; -gf;fk; 18
jpU%yh;; fUf;fil itj;jpak; gf;fk; -147
,uhkNjth; itj;jpa fhtpak; - 1000 gf;fk; 13
mfj;jpah; ghpG+uzk; - 1200 gf;fk; 221
A+fpKdp thjhq;f jPl;ir tpjp gf;fk; - 52
=uhkfphp rpj;jh; urhad rh];jpuk; gf;fk; - 44
JUR nrk;G - Gyj;jpah; thj #j;jpuk; - 300 gf;fk; - 21
mfj;jpah; gs;S ,UE}W gf;fk; 19> 78> 104>
JhpR fsq;F - Nghfk; 7000 Vohapuk; gf;fk; 49
JhpRRz;zn[aePH - mfj;jpah; thj nrskpak; gf;fk; 243
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JUR NrUk; fz;kUe;Jfs;
,uj;jpdhjp khj;jpiu
fdfhjp khj;jpiu
jhk;gpuhjp khj;jpiu
gr;ir khj;jpiu
re;jpNuhja cUz;il
nrhHz jhk;gpuhjp cUz;il
- ruNge;jpuh; ead Nuhfrpfpr;ir
tplf;fbf;fhd khj;jpiu
guQ;Nrhjp Fok;G
kfhrpe;jhkzp Fok;G
rQ;rPtpf; Fok;G
#lhkzp khj;jpiu
guzp kUe;J
- tp\itj;jpa rpe;jhkzp
ntspgpuNahf kUe;Jfs;
mQ;rdk;
ePyj;JUR> Jj;jk;> ntq;fhak;> #jk;> ePynuq;F> thsg;gUg;G>
mhpjhuk; ,itfs; tifnahd;Wf;F thuhfndil xd;W ,itfis
Nga;gPHf;fpiyr; rhw;why; miuj;J khj;jpiuahf; nra;J nfhz;L gzntil
ntw;wpiyr; rhw;wpyhtJ> Nga;g;gPHf;fpiyr;rhw;wpyhtJ ciuj;J tpopapy;
jPl;l m\;l ehfk; Kjypa tplf;fbahy; mlq;fpd caph; kPSk;.
- tp\itj;jpa rpe;jhkzp
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MODERN ASPECT
Arsenic Trisulphide ArS2S3 or Yellow orpiment
The word arsenic was borrowed from the syriac word zarniqa and the
Persian word Zarnikh, meaning "yellow orpiment" into Greek as arsenicon. It is
also related to the similar Greek word arsenikos, meaning "masculine" or potent.
The word was adopted in Latin arsenicure and old French arsenic, from which
the English word arsenic is derived.
Arsenic sulfides (Orpiment, realgar) and oxides have been known and
used since ancient times. As the symptoms of arsenic poisoning were somewhat
ill-defined, it was frequently used for murder until the invent of the Marsh test, a
sensitive chemical test for its presence, owing to its use by the ruling class to
murder one another and its potency and discreetness, arsenic has been called the
"king of Poisons".
Arsenic is a metalloid, atomic number 33 and relative atomic mass 74.92.
Sources and Occurences:
Arsenic occurs in many minerals, usually in conjunction with sulfur and
metals, and also as a pure elemental crystal. It was first documented by Albertus
Magnus in 1250.
The most common of the arsenic minerals is arsenopyrite, (FeAss). The
ability of arsenic to bind to sulfur ligands means that it tends to be found
associated with sulfide-bearing mineral deposits, either as separate as minerals
or as a trace of a minor constituent of the other sulfide minerals.
Arsenic and its compounds occurs in crystalline, powder, amorphous or
vitreous forms, they usually occur in trace quantities in all rock, soil, water and
air. However concentrations may be higher in certain areas as a result of
weathering and athropogenic activities including metal mining and smelting,
fossil fuel combustion and pesticide use.
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Physical characteristics:
The three most common allotropes are metallic grey, yellow and black
arsenic.
Yellow arsenic is soft and waxy and have four atoms arranged in a
tetrahedral structure in which each atom is bound to each of the other three
atoms by a single bond. This unstable alltrope, being molecular, is the most
volatile, least dense and most toxic. Solid yellow arsenic is produced by rapid
cooling of arsenic vapour As4.
Synthesis and reactions
Amorphous As2S3 is obtained by fusion of the element at 390°C. Rapid
cooling of the reaction melt ensures the disordered arrangement of the bonds
resulting in the glass. Like other chemical synthesis, pure precursors and the
exclusion of air provides purer product. The reaction can be represented with the
chemical equation
2As + 3S ASzSs
Arsenic is obtained as AS2O3 in the flux dust from roasting Cus, Pbs, Fes,
Cos, in air. The oxide may be converted to as by reduction with.
Yellow Arsenic
Composition
Arsenic trisulfide (61% As, 39%S)
Yellow arsenic is a sulphuretted oxide of arsenic. It is beautiful, bright
and pure yellow colour, not extremely durable in water, and less in oil. When
tint with while lead it is soon destroyed. It is not subject to discoloration in
impure air.
Although this pigment is not as poisonous as white arsenic, it is
dangerous in its effect upon health.
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Yellow orpiment is of several tints, from bright cool yellow to warm
orange. But orpiment, in all its varieties, powerfully deprives other substances of
their oxygen and therefore is subject to change and to be changed by every
pigment whose colour depend on that element and more especially all metallic
colour.
Yellow Arsenic is also called Minerals Yellow. It is prepared from
arsenic fluxed with litharge and reduced to powder. It is much like orpiment in
colour, dries well and not being affected by lead.  It is less liable to change in
tint. It must not be forgotten that it is poisonous.
Compound of Arsenic
Arsenic is a notoriously poisonous metalloid. It can exist in various
allotropes. Arsenic and its compounds are mainly used as an alloying agents for
lead batteries, but historically it was widely used as pesticides, herbicides,
insecticides but these applications are declining.
These are divided into two groups:
1. Organic compounds
2. Inorganic compounds.
Inorganic Arsenic compounds are
 Arsenic trioxide -AS2O3)
 (White Arsine, Arsenous Oxide)
 Arsenic trisulfide orpiment.
 Arsenous trichloride
 Arsenenous acid - HASO2
 Arsenic Pentoxide - AS2O5
 Arsenic Acid - H3ASO4
 Arsenic Acid - HASO3
 Arsenates
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 Salts of ortho - arsenic acid - H2 4ASO , 34ASO
Organic Arsenic compounds are,
 Arsenate
 Arseno - betaine
 Tetramethylarsonium ion
 Trimethylarsine oxide
 Dimethylarsinic acid.
 Trimethylarsine
 dimethylarsine
 methylarsine
 Arsenite
 Methylarsonic acid
 Arsenocholine
 Trialkylarsonioribosides.
 Arsonic acid
 Dimethylarsinoylribitol sulfate
 Arsphenamine (Salvarsan)
 Tryparsamide
 Nithrophenyl arsonic acid.
 Dialkyl dichloroarsine
 Alkyl dichloroarsine
Biochemical Aspects of Arsenic:
Metallic arsenic is not poisonous, as it is insoluble in water and therefore
incapable of being absorbed from the alimentary canal, but it oxidizes by
exposure to the air and then becomes poisonous. It is believed that arsenic may
undergo oxidation in the alimentary canal under some conditions and may
produce poisonous symptoms. The vapour emanating during smelling of arsenic
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ores destroying vegetation and animal life and cause chronic injuries effects to
smelters, pure arsenic dust is now believed to have toxicity.
Inorganic arsenic compounds, upon entering the food chain, are progressively
metabolized through a process of methylation. There is little danger in eating
fish because this arsenic compound in nearly non-toxic.
Arsenic can be taken in by ingestion, aspiration by breathing dust, and to
a much lesser degree by absorption through the skin. Accidental poisoning has
been reported to occur from wearing inadequate clothing when applying arsenic
based products.
Most of the ingested arsenic is absorbed through the G.I tract or
respiratory tract. After absorption 95-99% of the arsenic binds to globulin of the
haemoglobulin in erythrocytes. Then it is transported to other tissues and body
fluids with in 24 hrs.
Arsenic deposition occurs in bones, hairs, nails and skin. All arsenical
compounds inhibit sulphydryl enzyme system which is necessary for cellular
metabolism.
Arsenate causes its toxicity by uncoupling mitochondrial oxidative
phosphorylation. It interferes with glycolysis.
External:
Arsenic when applied on raw surface it is a powerful caustic used to
destroy growth, lupus and warts. It plays a major role in the treatment of
syphilitic chancre.
Medical use:
 Arsphenaminc was indicated for trypanosomiasis.
 The US food and drug administration approved this compound for
the treatment of patients with acute promyclocytic leukemia.
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 It was used as fowler's solution in psoriasis.
 A new research has been done in locating tumours using arsenic –
74 (a position emitter)
 In subtoxic doses, soluble arsenic compounds act as stimulants.
In Siddha and Ayurveda
Yellow orpiment is used in large amount. It is poisonous in commercial
form. After purification only it is used for medicinal preparation. Arsenic
(Haritaram) is combined with other metals, minerals and used for skin diseases,
syphilis, urinary tract infections, fever, bronchial asthma etc.,
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THURUSU IN MODERN ASPECT
THURUSU
1. Cupri sulphas
2. Cuprum sulphas
3. Cupric sulphate
4. Copper sulphate
Chemical symbol of copper sulphate (Thurusu) is = Cuso45H2O
VERNACULAR NAME
Sanskrit : Thutta, Nella Tuta, Thutham, Mayura thutham Sikhigrivam
Hindi : Nila-thotha: nila tuta
Gujarathi : Mor-tuta
Malay : Toorshi, Turi
Barma : Doutha
Tamil : Mayil thutham, Tutam, Thurisi
Telugu : Mayilu thuthamu
Arab : zajul-alcher.
English : Verdigris, Crude copper sulphate, copper acetate, Basic
copper acetate, Blue coperas, Blue stone, Roman vitriol.
- Commercially Thurusu is  known as Blue vitriol Copper sulphate
MOLECULA FORMULA: CuSO45H2O
1. Physical and chemical characteristics: Bluish crystal of triclinic
form, odorless, liable to be efflorescent and surface turns into
white powder specific gravity is 2.284.
2. Dissolves in water, ammonia liquor and thin ethyl alcohol and not
dissolves in anhydrous ethyl alcohol, shows faintly acid reaction in
its water solution.  It loses 4 crystal water when heated 110 C and
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forms white anhydrous copper sulphate over 150C.
Specifications: Name Norm (-) Norm(=) Cupric sulphate (CuSo4
5H2O%) > 9698.  Water insoluble (%) < 0.20.02 free sulfuric acid
(%) < 0.10.01.
3. Uses: it is an imporatant raw material in the preparation of other
nantokite in chemical industry, widely used in industry of dyestuff
mordants, pigments, pharmaceutics, synthetic silk, leather, copper
electroplating, catalysts and pesticides, etc.
4. Package: Being packed into 50 kgs woven bags with inner plastic
bags.
Testing by scientists at the Northern Terrotory university and Department
of primary industry and fisheries and international scentific advice on the use of
copper sulphate to kill spat, juveniles and adult black striped mussel, Congeria
sallei, has produced the following results.
1. Copper sulphate applied at 1.0 parts per million in seawater will
begin to kill the mussels after 24 hours under experimental
conditions.  It may take longer than this in the marinas.
2. This application rate does not kill all other marine life (although
smaller fish and crustaceans may be killed.)
3. The level of organic matter in the sea water affects the availablity
of the copper sulphate.  Where there is a high level organic matter
the coppe will not be available to kill the mussels as it will be
bound with the organic matter.
4. The best available advice is that there will be no adverse effect on
aluminium hulls, drive legs and other waterline or underwater
fittings on boats which are fitted with sacrificial anodes.  The zinc
in the anodes is the only metal scrificed.
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MEDICAL VALUE OF THURUSU
1. Thurusu is a powerful astringent emetic and antiseptic
2. Externally it is stimulant, styptic and mild caustic
3. Doses as an astringent is 1/8 th to 2 grains;  as an emetic it is 50
grains, used in cases of poisoning by narcoties such as opium
nuxvomica, arsenic etc.
4. In chronic diarhoea purified copper sulphate is doses of ¼ to 2
grains is benefical.
5. In the diarrhoea of the advanced stages of phthisis, copper sulphate
and opium ½ grain of each in pill from mixed with honey is given
thrices daily.
6. It is contained in medicines named grahnikapata Rasa which is
useful in bowel disease such as chronc diarrhoea and dysentery
and especially sprue.
7. In garbhabilassa Rasa (or) Sutikabindu which are recommended
for puerperal diseases like puerperal diarrhoea and
indigestionduring pregnancy.
8. In jayamangela Rasa, Mahamrityunijaya Lauha, Putapakwa
visamas warantaka Lauha, Javarankusha and chakurthakari which
are used in intermittent and relapsing fevers with enlarged spleen
and liver.
9. In cases of diarrhoea in children a mixture made of copper sulphate
21/2 grains.  Ajowan water 2 ounces is useful in doses of a
teaspoonful doses daily.
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10. In cases of diphitheria and croup in children a solution of copper
sulphate (5 grains to an ounce of water) in teaspoonful doses evens
½ hour till vomiting is produced.
11. It is useful in cases of poisoning copper sulphate 4 grains,
dissolved in hot water is given every few minutes till vomiting
occurs.
12. Externally copper sulphate is applied to indolent colours,
exuberant granulations, sinuses and fistula in ano in solid or
prefereably liquid form as solution.  An ordinaly Pichu or clean
cotton or a piece of cloth boiled in samudra lavana 1 tola in 1
measure or padi of water and there cloth pieces preserved in wide-
mouthed glass bottles so as not to be contaminated with dust, are
used in lieu of gauze etc., as dressing for wounds.  Whesres
sodhana is required these cotton pieces may be dripped in a
solution at mayilthutham and applied.
13. An oinment known as Oleatum cupri (B.P.) is highly
recommended in parasitic disease of skin, in ringworm, indolent
ulcers etc.  In priclaly heat a solution of copper sulphate in rose
water after gives reliet.
14. In ring worm an ointment made of copper sulphate 10 grains,
powdered galls 1 dr and and ounce of cesromel rubbed on the
affected park.  Though it smarts is very effective.
15. In eye diseases, chakradhata recommends a weak solution of
copper sulphate to be droped in to the eye in opacties of the
cornea.  A half precent solution may be used in conjuctivitis and
ophthalmia with copious discharge.
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16. In heamorrhage from the nose and other forms at bleeding from
mucous surfaces, solutin of CuSO4 4 grains to 1 ounce at water, is
effective as a nasal douche even when alum tails.  It there is
excessive bleeding from wound due to leach bite, application at a
little powdered CuSO4 is useful when alum fails.
17. In leucorrhoea and gonorrhoea it may be used as an astringent and
antiseptic vaginaol or urethral injection.
18. In ulceration of mouth CuSO4 2 grains in a little honey may be
applied to the ulcers.
19. Incases of poisoning by Opium, dhatura, nux vormica, coeurcus
indicus, aconite, arsenic etc copper sulphate solution given at a
drought alts promptly as a good emetic.
20. In cases of burn from phosphorus, cotton pads soaked in 1 present
solution of copper sulphate are useful.
- Indian Material Medica
 Dr.K.M. NADKARNI
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STRYCHNOS POTATORUM
Kingdom  : Plantae
Division  : Magnoliophyta - Flower plants
Class : Magnoliopsida - Dicots
Order : Gentianales
Family : Loganiaceae
Habitat - Deccan, Peninsula, India, Ceylon.
- Materia medica of India & their therapeutics
Kankan, N. Kanara, Madhya Bharat, N. Circars, Deccan, Carnatic to
South Travancore
- Glossary of Indian medicinal plants
R.N. Chopra, Nayar, IC chopra P.No : 236
Parts used :        The seeds
Characters :        Fruit shining and black.
Seeds orbicular, button shaped and smaller in size than those of kuchala.
Each having at its border a projecting ridge. Integument yellowish and covered
with hairs. Albumen copious and horny, but not so hard as that of nux vomica.
No taste. Dose of the powder as an emetic, l/21r; as a demulcent, 10 to 15 grms.
Contains no strychnine but brucin is Present.
STRYCHNOS POTATORUM
Lunm f. suppl. (1781) 148-PLATE 633B.
A moderate sized glabrous tree attaining 12m: bark black, cracked and
Scaly, trunk often irregularly fluted. Leaves 5-7.5 by 2.5-4.5cm nearly sessile,
subcoriaceous, ovate or elliptic, acute or subacuminate, glabrous and shining,
spuriously 3 or 5 nerved, base rounded or acute, petioles 2.5mm long. Flowers
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rather large for genus, in short almost glabrous nearly sessile auxiliary cymes;
peduncles 0.5mm. long; pedicels very short, calyx 2mm, long, glabrous,
segments 5, ovate, acute, 1.25mm long. Corolla 4-6mm. long, 5-lobed; lobes 2.5
mm long, oblong, acute, with a tuft of hair inside towards the base of each lobe
ovary ovoid, glabrous, tapering into a long glabrous style; stigma obscurely 2
lobed. Berry black when ripe, 1.7 cm. diam. Seeds 1 or 2, circular, 8mm, diam,
bluntly lentialar, not greatly compressed, shining with short oppressed silky
hairs, yellow.
The plant is acrid, bitter, alexiteric, anthelmentic. It increase appetite and
improves taste; good in troubles of the eyes, thirst, burning sensation, tumours,
pains, urinary discharges. The root cures all kinds of leucoderma. The unripe
fruit is useful in diseases of the eye, thirst, poisoning, hallucinations; increased
'Vata'. The ripe fruit is emetic, diaphoretic, alexiteric; cures inflammations,
anaemia, jaundice and causes biliousness.
The seeds are acrid; alexipharmic, lithontriptic, good in disease of the
eye; cure strangury, urinary discharges, diseases of the head (Ayurveda)
The seeds have a bitter bad taste; astringent to the bowels, aphrodisiac,
tonic, diuretic; good for the liver, in kidney complaints, in gonorrhoea; improve
the eyesight; relieve colic; a good remedy for snakebite. (Unani)
The use at the seeds for the purpose at clearing muddy water, is as old as
susruta, who mentions it in his chapter on water. Medicinally, they are chiefly
used as a local application in eye diseases. The seeds are rubbed with honey and
a little camphor, and the mixture applied to the eyes in lachriymation or copious
watering from them. Rubbed with water and rock salt, they are applied to
chemosis in the conjunction.
In long - standing and chronic diarrhoea which resists all treatment,
one-half or a full seed, rubbed up into a fine paste with some Buttermilk and
given internally for one week, is said to be effectual.
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In Chennai, the seeds are used in diabetes and gonorrhoea.
S. Potaforum; lin.
Leaves elliptic subsessile glabrous or nearly so, cymes axillory nearly
sessile, berry 1/3-2/3 in diameters 1-2 seeded
DECCAN PENINSULA extending north-west to the some river.
A tree, attaining 40 ft. Leaves 2,1/2 by linch, acute at both ends, hardly
acuminate, 3 nerved from the base or more often the lateral nerves springing
much higher, or sub - Penninerved; petiole 1/10 inch. Peduncles 0-1/5 in; cymes
1 in diam nearly glabous; pedicels hardly any. Corolla - tube 1/8 - 1/6 in, hardly
twice as long as broad, hairy within, nearly glabrous; stigma small capitates.
Seeds lA - 1/3 in diam, hemispheric, subpeltate, hardly discoid - The clearing
nut.
- Hooker Flora at India Vol IV page 90
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PHYTO CHEMISTRY
Estimation of phytochemicals of S. Potatorum
S.No. Metabolites %  at secondary metabolites (in seed)
1. Alkaloids 1.3%
2. Plaxonoids 0.021%
3. Phenols 0.059%
4. Tannins 18.00%
5. Saponins 4.74%
An alkaloid - diaboline - isolated (Phytochemistry 1975, 14, 587)
p-Sitosterol and Stigmasterol isolate from seeds (Planta Med. 1975, 28, 392);
Oleanolic acid and its 3(3-acetate and 2 saponin containing Oleanolic acid,
Galactose and Mannose isolated from seeds; glalactose and mannose also
isolated as free sugars (planta meel. 1977.32.362); a new triterpene-isomotiol
(fern-8-en-3p-01)- isolated from leaves; mixtures of sitoserol, stigmasterol and
campesterol obtained from leaves and bark (Phytochemistry 1978, 17, 154);
quercetin and Vanillic, Syringic, 2 hydroxy-4-methodybenzoic chlorgenic and
sinapic acids found in plant (Curr.Sci 1979) New Compounds.
Medicinal Uses:
In chronic diarrhoea, diabetes, gonorrhoea, and Irritation at the Urinary
organs, and externally in lachrymation, chemosis in the conjuctiva and to boils.
- Indian Materia Medica - vol.2
Dr.K.M.Natkarni. P.No : 308
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Seeds used as a local application in eye diseases, rubbed with honey and
little champhor, the mixture applied to the eyes in lachrymation or copious
watering; used as emetic in dysentery, in diabetes and gonor.
- Glossary of Indian Medicinal Plants
R.N. Chopra, Nayar, IC Chopra P.N : 236
The seeds are used for purifying muddy water.   This property is due to
their containing albumen and caseine.
It is used to prevent lachrymation & to remove opacities; also applied to
the abdomen to relieve colic. Its infusions is recommended in irritation of the
urinary organs, as ganorrhoea, diabetes and as an emetic in cough.
Materia Medica of Indian and their Therapeutics Rustomjee & Nanabhai.
P.No:408.
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HONEY (ANUPANAM)
Synonyms:Madhu, Honey Purified, Mel
Sanskrit madhu, makshika
Hindi Madha
Tamil Taen
Malayalam Taen
Telugu Taen
Biological Source
Honey in a sugar secretion deposited in honey comb by the bees, Apis
mellifica, Apis dorsata, and other species of Apis, belonging to order
Hymenoptera, family Apidae.
Preparation
Nectar of the flowers is a watery solution containing 25% sucrose and
75% water. The worker bee sucks this nectar through its hollow tube of mouth
(proboscis) and deposits in honey-sac located in abdomen. The enzyme
invertase present in saliva of the bee converts nectar into invert sugar, which is
partially utilized by the bee and the remaining is deposited in the honey comb. It
is smoked to remove the bees and honey is obtained by applying pressure to it
or allowing to drain naturally. The honey of commerce is heated to 80°C and
allowed to stand. The impurities which float over the surface are skimmed off
and liquid diluted in with water to produce honey of 1.35 density. Natural honey
has density of 1.47. Many a times honey is extracted from the comb by
centrifugation. It must be free from foreign substances. Honey is liable for
fermentation, unless it is suitably processed. Honey is heated to 80c before it is
sent to the market so as to avoid fermentation it should be cooled rapidly or else
it darkens in colour on keeping.   If necessary, honey is filtered through a wet
cloth or flannel.
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Description
Colour Pale yellow to yellow brown
Odour characteristic, pleasant
Taste sweet and faintly acrid
Standard
Weight 1.35 to l.36 g
Specific rotation +3° to -10
Total ash 0.1 to 0.8%
Extra Features
It is syrupy thick liquid, translucent when fresh and on keeping it
becomes opaque and granular due to crystallization of glucose.
Solubility
It is soluble in water and insoluble in alcohol.
Chemical Constituents
Honey is an aqueous solution of glucose 35%, fructose 45% and sucrose
about 2%. The proportion of sugar may vary depending upon source of the
nectar and enzymatic activity responsible for converting nectar in to honey. The
other constituents of honey are maltose gum traces of succinic acid, acetic acid,
dextrin and formic acid, colouring matter, enzymes (inverstase, diastase,
inulase) and traces of vitamins. Protein and pollen from various flowers are
found in honey. Since honey is saturated solution of sugar on keeping it starts
crystallizing. A product which contains crystallized dextrose is called as
granulated honey. Heating also minimizes granulation.
57
Action
New honey is considered demulcent and laxative. Honey more than a
year old is considered astringent, demulcent, detergent, emollient and laxative.
It also possesses nutritive properties. Fatty acids present in honey stimulate
peristalsis digestion. Honey in moderate doses has a beneficial effect on the
digestion and appetite. Its value lies in proving a readily absorbable food.
Lime in honey is wonderful in regulating the secretions of internal
glandular organs, being equally good for persons of both sexes irrespective of
age from infancy to old age. Again it has hypnotic action if taken in cold water
before going to bed. Babies fall asleep immediately after taking honey. It
decreases flatulence and increases general metabolism and increases also
quantity of urine amount children. Locally it stimulates mucus membrane, when
in an atonic condition. It also acts as a styptic.
It is used as an antiseptic and applied to burns and wounds. It is a
common ingredient of several cough mixtures, cough drops and a vehicle for
siddha formulations. Recently it is used in the preparation of creams, lotions,
soft drinks and candies.
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TOXICOLOGICAL ASPECT
Arsenic Toxicity
Arsenate can replace inorganic phosphate in the step of glycolysis that
produces 1, 3-bisphosphoglycerate, yielding l-arseno-3- phosphoglycerate
instead. This molecule is unstable and quickly hydrolyzes, forming the next
intermediate in the pathway, 3-phosphoglycerate. Therefore glycolysis proceeds,
but the ATP molecule that would be generated from 1,3-bisphosphoglycerate is
lost - arsenate is an uncoupler of glycolysis, explaining its toxicity.
Metal Arsenic is not absorbed from the alimentary canal. When
volatalised by heat, arsenic unites with oxygen and forms poisonous vapour of
arsenic trioxide. Arsenious oxide or arsenic trioxide is the most poisonous
compound.
A lethal dose of Arsenic can also be achieved by a cumulative process
over two months. Multiple sub-lethal doses received over a period of several
weeks can accumulate in the body to achieve a lethal dose. And at very small
doses, arsenic is carcinogenic.
Exposure to high levels of inorganic arsenic- greater than 100 ppm parts
of arsenic in food or water - can also be fatal. Arsenic and arsenic compounds
are known cancer - causing agents and have been implicated in lung and skin
cancer and associated with birth defects. While organic arsenic (arsenic
combined with carbon compounds) is less toxic it causes similar effects.
However, in subtoxic doses, soluble arsenic compounds act as stimulants.
Fatal dose
180 mg to 200 mg - average adult.
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Fatal period:
If a very high dose has been taken death may occur within half an hour.
With usual fatal dose death may occur within 24 hrs. But it usually takes 3-7
days for death to come.
Absorption, distribution and elimination:
All toxic compounds of arsenic are absorbed through mucous membrane
of the gastro intestinal tract. Gaseous arseno and arsenical dust are absorbed
through the Lungs. Mixed with suitable solvent it may be absorbed through the
skin. Arsenic is deposited in liver, kidney, bones, hairs and nails. In liver and
kidney, the quantity deposited is more marked after acute intoxication.
Excretion
Excretion of Arsenic is through urine, bile, faeces and sweat.
Acute poisoning
The first symptoms of acute arsenic poisoning by ingestion are digestive
problems:   vomiting,   abdominal   pains,   diarrhoea   often   accompanied   by
bleeding.
Effects of Acute poisoning from inhalation includes:
 Loss of appetite
 Nausea
 Diarrhoea
Sub acute Poisoning
The appearance of symptoms takes more time and the neurotic symptoms
predominate.
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Sub-lethal doses can lead to convulsions, cardiovascular problems,
inflammation of the liver and kidneys and abnormalities in the coagulation of the
blood. These are followed by the appearance of characteristic white lines) (Mees
stripes) on the nails and by hair loss. Lower doses lead to liver and kidney
problems and to changes in the pigmentation of the skin.
Effects of sub acute exposure to arsenic include
 'Pins and Needles' tingling in the palms, or cramps in calf muscles.
 Heat and irritation in throat and stomach, a garlic odour on breath,
or a metallic taste in the mouth.
 Vomiting, purging with very loose stools.
 Neurological effects including Restlessness, Chronic headaches,
Apathy, Fainting, Dizziness, Delirium, Convulsions or Coma.
Chronic Poisoning
Chronic arsenic poisoning is known as "arsenicosis". It may follow
acute poisoning of Arsenic, particularly in recovery cases from heavy poisoning.
Signs of chronic exposure include:
 Development of white crescent-moon marks on the fingernails
called
'Aldrich-Mee's lines'.
 A darkening of the skin, skin lesions, a skin rash and the
appearance of Small warts on the palms, soles and torso, mottled
spotting of the skin pigmentation, looking like 'raindrops on a
dusty road'.
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Mode of Death
 Dehydration - Shock.
 Convulsion - Renal failure.
 Pulmonary oedema.
Autopsy findings External:
Rigorrnortis lasts longer than usual. The body appears shrunken due to
dehydration, the eye balls are sunken, and the skin is cyanosed.
Internal:
Mouth:
Lips shows blistering.
G.I.T:
Stomach shows characteristic feature even if arsenic taken parenterally.
On stomach opening, food particles mixes with gritty sandy particles of arsenic
or a dark brown odourless, turbid, liquid with crystal form arsenic embedded in
large masses of mucous. Inner wall of stomach is swollen, softened, congested
and tinged with streak of blood and white or yellow particles of arsenic
embedded in the mucous of lymph covering it. Very crude form of arsenic
ingestion leads to mucosal ulceration.
Liver, Spleen, Kidney
The liver, Spleen and kidney are highly congested, enlarged and may
show scattered signs of fatty infiltration and degeneration. Cloudy swelling and
fatty degeneration of myocardium, Liver and Kidneys are seen.
Lungs
Lungs are congested and echymotic.
Heart
Sub endocardial haemorrhage.
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TREATMENT
Arsenic is cleared from the body quickly, so the most important remedy
for arsenic poisoning is eliminating exposure.
Acute arsenic Poisoning
Subjects with suspected arsenic poisoning should always be directed to
immediate medical care. There are no actual antidotes to neutralize the arsenic
poisoning but the best way that can be done immediately after ingestion is to
make the subject to vomit immediately after ingestion. Gastric Lavage or
emetics (apomorphine, zinc sulfate, mustard, ipecac, milk of magnesia, even
burnt toast) should be continued under a doctor's supervision at intervals up to
two days, then castor oil is given. I.V fluids will likely be necessary to prevent
from dehydration.
Once arsenic has been ingested, the best treatment may be to introduce
agents to bind to the arsenic and help to prevent it toxic effects. Chelating agents
such as "British Anti-Lewisite"(BAL) work by binds arsenic tightly in
complexes, making it inactive. Chelating agents have shown good success. This
can help to deactivate arsenic and remove it from a person's body, protecting
from averting severe toxicity and death.
mhpjhu eQ;Rf; FwpFzq;fs;
mhpjhuj;ij kUe;Jfspy; cgNahfg;gLj;Jq;fhy; Rj;jp> nra;Kiw>
msT> gj;jpak; Mfpait jtwpd; eQ;rhFk;.
mt;thW tplkpj;jhy;>
 eff;fz;zpy; ,uj;jk; Rthpg; gf;Ffl;bg; Gz;zhfp rPo; tbAk;.
 tapw;wpy; vhpr;riy cz;lhf;Fk;.
 thapiyf;Fk;.
 %f;fpypUe;J ,uj;jk; nfhl;Lk;.
 RitnfLk;.
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 czT cl;nfhs;shky; ntWg;ig cz;lhf;Fk;.
 jiyapy; eikAz;lhfp kaph; Kid rpte;J neUg;Gf;
nfhOe;jpd; epwj;ij xj;jpUf;Fk;.
 Nkw;Rthrj;ij fpsg;gp ke;jpf;fr; nra;Ak;.
 gpukpf;Fk;.
 mbtapw;wpy; tPf;fr; rhaiy fhl;Lk;.
 ,ilf;Fg; gf;fj;jpy; jPuhj typiaf; nfhLf;Fk;.
Kjypa jPf;FwpFzq;fis cz;lhf;Fk;.
(Mjhuk; : Fzghlk; jhJ [Pt tFg;G – gf; 256> Njiuah; akf
ntz;gh ciu> eQ;R KwpT E}y;> gf;fk; 28)
jhsfk; eQ;R KwpT
“NjUtha; jhsfj;ijj; jpd;Nwhh;f;F ePypajd;
NtUlNd ahtpuk; g+ ntl;bNth; - rPufKk;
khjistpj; njhL njd;dk; td;FUk;ig fhrpdpNth;
jPjfy ew;FbePh; nra;”.
ePypNth;> Mthuk;g+> ntl;bNth;> rPufk;> khJistpj;J>
njd;dq;FUk;ig> fhrpdpNth; ,itfis tiff;F fhy; gyk; $l;bf;
FbePh; nra;J mUe;j jhsfj;jhy; tpisAk; eQ;R jPUk;.
 rpj;jpu%y Nth;g;gl;il> kpsF – tiff;F 8.75 fpuhk;
,tw;iw FbePhpl;L fwpAg;G 4.37 fpuhk; Nrh;j;J fhiy> khiy>
Nehapd; tplj;jd;ikf;F Vw;g miu Kjy; xU kz;lyk; (48 ehl;fs;)
nfhs;s Ntz;Lk;.
- Fzghlk; jhJ rPt tFg;G gf;f vz;. 343
 mThp Nth;g;gl;il – 8.75 fpuhk;
 Mthuk; - 8.75 fpuhk;
,jid FbePhpl;L. fwpAg;G 4.37 fpuhk; Nrh;j;J fhiy> khiy fye;J
mUe;j mhpjhu eQ;R ePq;Fk;.
- mDNghf itj;jpa etePjk; ghfk; 6 gf;fk; 14
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COPPER SULFATE
Copper sulfate is a fungicide used to control bacterial and fungal
diseases of fruit, vegetable, nut and field crops. Some of the diseases that are
controlled by this fungicide include mildew, leaf spots, blights and apple scab. It
is used in combination with lime and water as a protective fungicide, referred to
as Bordeaux mixture, for leaf application and seed treatment. It is also used as an
algaecide, an herbicide in irrigation and municipal water treatment systems, and
as a molluscicide, a material used to repel and kill slugs and snails. Copper
sulfate is a naturally-occurring inorganic salt and copper is an essential trace
element in plant and animal nutrition .It is available in the following
formulations: dusts, wettable powders, and fluid concentrates.
TOXICOLOGICAL EFFECTS
ACUTE TOXICITY
Copper is one of 26 essential trace elements occurring naturally in plant
and animal tissue. The usual routes by which humans receive toxic exposure to
copper sulfate are through skin or eye contact, as well as by inhalation of
powders and dusts .Copper sulfate is a strong irritant
Copper sulfate is only moderately toxic upon acute oral exposure. There
have been reports of human suicide resulting from the ingestion of gram
quantities of this material .The lowest dose of copper sulfate that has been toxic
when ingested by humans is 11 mg/kg .Ingestion of copper sulfate is often not
toxic because vomiting is automatically triggered by its irritating effect on the
gastrointestinal tract. Symptoms are severe, however, if copper sulfate is
retained in the stomach, as in the unconscious victim. Some of the signs of
poisoning which occurred after 1-12 grams of copper sulfate was swallowed
include a metallic taste in the mouth, burning pain in the chest and abdomen,
intense nausea, vomiting, diarrhea, headache, sweating, shock, discontinued
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urination leading to yellowing of the skin. Injury to the brain, liver, kidneys and
stomach and intestinal linings may also occur in copper sulfate poisoning.
Copper sulfate can be corrosive to the skin and eyes. It is readily absorbed
through the skin and can produce a burning pain, along with the same severe
symptoms of poisoning from ingestion. Skin contact may result in itching or
eczema .It is considered a skin sensitizer and can cause allergic reactions in
some individuals .Eye contact with this material can cause: conjunctivitis,
inflammation of the eyelid lining, excess fluid buildup in the eyelid; cornea
tissue deterioration due to breaks, or ulceration, in the eye's mucous membrane;
and clouding of the cornea.
The amount of copper sulfate that is lethal to one-half (50%) of
experimental animals fed the material is referred to as its acute oral lethal dose
fifty, or LD50. The LD50 for copper sulfate is 30 mg/kg in rats. Ingestion by
animals of three ounces of a 1% solution of copper sulfate will produce extreme
inflammation of the gastrointestinal tract, with symptoms of abdominal pain,
vomiting, and diarrhea. When copper sulfate is given intravenously, or injected
into the vein, as little as 2 mg/kg copper sulfate is lethal to guinea pigs; and 4
mg/kg is lethal to rabbits.
CHRONIC EFFECTS
Vineyard sprayers experienced liver disease after 3 to 15 years of
exposure to copper sulfate solution in Bordeaux mixture .Long-term effects are
more likely in individuals with Wilson's disease, a condition which causes
excessive absorption and storage of copper .Chronic exposure to low levels of
copper can lead to anemia .The biological or chemical manner by which
excessive doses of copper sulfate work is not well understood.
The growth of rats was retarded when 25 mg/kg of copper sulfate was
included in their diets. 200 mg/kg caused starvation and death .Sheep with
access to salt licks that contained five to nine percent copper sulfate showed
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signs of absence of appetite (anorexia), anemia, and degenerative changes,
followed by death within one or two days of exposure. This material caused a
significant increase in the death rates in mice that were exposed to an air level
equivalent to human inhalation exposures.
The EPA limit for copper sulfate in drinking water is 1 ppm. This limit
has been set to prevent a disagreeable taste from copper in drinking water, as
well as to provide adequate protection from toxicity.
Reproductive Effects
Developing embryos were resorbed in pregnant hamsters given copper
salts intravenously on the eighth day of gestation. Testicular atrophy increased in
birds as they were fed larger amounts of copper sulfate. Sperm production was
also interrupted to varying degrees .Reproduction and fertility was affected in
pregnant rats given this material on the third day of pregnancy .EPA does not
require data on the reproductive effects of copper sulfate in mammals.
Teratogenic Effects
Heart disease occurred in the surviving offspring of pregnant hamsters
given intravenous copper salts on the eighth day of gestation .EPA does not
require data on the teratogenic effects of copper sulfate .
Mutagenic Effects
At 400 and 1,000 ppm, copper sulfate caused mutations in two types of
microorganisms .Data on the potential mutagenic effects of this material is not
required by the EPA.
Carcinogenic Effects
Ten mg/kg of copper sulfate caused endocrine tumors in chickens given
the material parenterally, that is, outside of the gastrointestinal tract through an
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intravenous or intramuscular injection .EPA does not require this data for copper
sulfate.
Organ Toxicity
Examinations of copper sulfate-poisoned animals showed signs of acute
toxicity in the spleen, liver and kidneys .Injury may also occur to the brain, liver,
kidneys and gastrointestinal tract in response to overexposure to this material.
Fate in Humans and Animals
Absorption of copper sulfate into the blood occurs primarily under the
acidic conditions of the stomach; the mucous membrane lining of the intestines
acts to some extent as a barrier to absorption of ingested copper .After ingestion,
more than 99% of copper is excreted in the feces. Copper is an essential trace
element that is strongly bioaccumulated .It is stored primarily in the liver, brain,
heart, kidney and muscles. About one-third of all the copper in the body is
contained in the liver and brain. Another third is contained in the muscles. The
remaining third is dispersed in other tissues.
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STRYCNOUS POTATOROM
Toxicological Aspect
It is highly toxic to humans and most domestic animals and is used
mainly as a rodenticide. Over the years the cancellation of registrations of agents
containing strychnine has reduced its usage throughout the world [3]. Israeli
authorities have prohibited its use, as have Britain and the European Union, yet
it is still in use in other Middle Eastern countries. Veterinarians are allowed to
employ it under specific circumstances, e.g., to prevent the spread of rabies. In
the last 20 years human poisonings occurred mainly due to ingestion of the
poison in suicidal and homicidal attempts. The lethal dose for human adults
ranges between 30 and 120 mg, although death of an adult has been reported
after an ingestion of 16 mg. The lethal dose for children is about 15 mg [4,5].
Though strychnine is lethal to humans, early aggressive treatment can be life
saving, even following exposure to large doses as high as 3750 mg [6]. In view
of the rise in global terrorism, it is important to recognize that strychnine may be
utilized by terrorists to induce mass poisoning in urban populations by
contamination of major food and water supplies.
This short review focuses on the unique clinical effects of strychnine and
the proposed medical care that should be employed in case of strychnine
poisoning.
Chemical properties and mechanism of action:
Strychnine is a colorless, odorless, bitter-tasting chemical. Strychnine
dissolves in acidic media but dissolves poorly in either water or ether [7]. The
chemical has a very low vapor pressure and decomposes to release toxic
combustion products, such as carbon monoxide, carbon dioxide and various
nitrogen oxides [8]. Strychnine   interferes with post-synaptic  inhibiturns into
powder in dry air. The chemical structure of strychnine tion mediated by glycine,
especially in the ventral horns of the spinal cord, brainstem and higher centers. It
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blocks recurrentinhibition at the Renshaw cell-motor neuron synapse by
ompetitively antagonizing the action of glycine released by these cells [9-11].
The loss of post-synaptic inhibition results in excessive motor neuron activity
and convulsions [9,10]. Central nervous system involvement may also bring
about exaggerated responses to visual, auditory and tactile stimulation. Even the
slightest breeze may evoke a new set of convulsions [2,12,13].
Pharmacological properties
Strychnine is absorbed very rapidly through the gastrointestinal tract, the
respiratory tract and intact skin [14,15]. In addition, it is well absorbed when
given via the parenteral route (subcutaneous or intranasal). The first symptoms
usually appear within 5 minutes to 1 hour after exposure, depending on the dose,
the route of ex- posure, and the general medical health of the person exposed. It
undergoes rapid and extensive metabolism by hepatic cytochrome P-450 2B and
it does not seem to have an accumulative effect [2,5]. Five metabolites formed in
vitro by rabbit liver were isolated and purified. Three of them were identified as
2-hydroxystrychnine, strychnine N-oxide, and 21-α,2 2-β-dihydroxy-22-
hydrostrychnine, when compared to authentic samples by means of  ultraviolet,
nuclear magnetic resonance and mass spectrometries. Additionally, two other
metabolites were tentatively identified as strychnine by spectral measurements:
21, 22-epoxide and 11,12-dehydrostrych-nine. Strychnine N-oxide was the major
metabolite and accounted for approximately 15% of the metabolized strychnine.
All other metabolites accounted for < 1% [16].
The combination of detoxification and excretion renders strychnine a
biological half-life (in humans) of 10–12 hours [2,17]. Up to 20% is excreted
unchanged in the urine within 24 hours [2].
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Health effects
Most strychnine poisonings occur through ingestion or inhalation, while
only a few cases are due to topical exposure. Clinical manifestations begin with a
prodromal stage.
Prodromal stage
Prodromal symptoms may often occur within 15–30 minutes following
ingestion or 5 minutes after inhalation. In case of a topical exposure, the
prodromal period may last up to 14–15 hours [14]. These symptoms include
apprehension, restlessness, a heightened sense of awareness (hearing, vision,
tactile sensation, etc.), hyperreflexia and muscular stiffness of face and legs.
Vomiting is uncommon [2].
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Clinical stage
The clinical hallmark of this stage is manifested mainly by recur- rent
violent seizures while the victim is fully alert [2,12]. Short yet violent
convulsions lasting from 30 seconds to 2 minutes are triggered even by a faint
sensory stimulus. The combination of convulsions with intact sensorium is the
most noticeable manifestation of strychnine poisoning.  These convulsions are
clonic at first, and then become tetanic with opisthotonus, trismus of the jaws,
and the appearance of “risus sardonicus” (a grinning expression produced by
spasm of the facial muscles). The eyes protrude in a fixed stare. Tetanic
contractions of the diaphragm, thoracic muscles and abdominal muscles prevent
normal respiration, generating anoxia and cyanosis. The convulsions may be ac-
companied by mydriasis, proptosis, and conjugated or dissociated deviations of
the eyes. Full consciousness is present throughout the seizure and the victim
remains anxious, frightened and in pain. Complete muscular relaxation occurs
between the convulsions, when the victim is breathing and cyanosis disappears.
Dilated pupils may contract and the victim may fall asleep from exhaustion.
These intervals usually last for up to 10–15 minutes and are interrupted by
additional spasms triggered even by a draft of air [2]. Usually there are between
one and ten attacks; each is more intense than the previous one, with shortening
of the intervals. In the absence of effective treatment (and occasionally despite
it), the victim rarely survives the fifth spasm and dies from respiratory arrest. If
the victim survives the first 5–6 hours, the prognosis is favorable [2]. Possible
complications include hyperthermia, respiratory and metabolic acidosis,
rhabdomyolysis and myoglobinuric renal failure. Anoxic brain
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Table 1
Major human health effects following strychnine poisoning
System Prodromal stage Clinical stage
Eyes Exophthalmus, mydriasis, bilateral
horizontal pendular nystagmus
Skin Allergic response Hypersensitivity
Respiratory tract Spasmodic diaphragm movements,
cyanosis, dyspnea, hypoxia,
respiratory failure
Central nervous
system
Restlessness,
apprehension, cold
perspiration,
heightened acuity
of perception
Tremor, violent repeated convulsions
with opisthotonus, impairment of
short and medium-term memory
Gastrointestinal
tract
Vomiting
(uncommon)
Vomiting
Cardiovascular Weak pulse, tachycardia,
hypertension, cardiac arrest
Renal and urinary
tract
Myoglobinuria, acute renal failure
Musculoskeletal
and smooth
muscles
Stiffness of facial
and neck muscles,
hyper-reflexia
Contractions  of all voluntary muscles
simultaneously, including chest and
abdominal muscles, hypertonicity of
the muscles, tonic twitching of the
face and neck muscles, trismus, risus
sardonicus, rhabdomyolysis
Metabolic Hyperthermia
Laboratory
findings
Lactic acidosis, hyperkalemia,
elevations of AST, LDH, CPK,
leukocytosis
Carcinogenicity Not considered a carcinogen
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     THALAGAM     THURUSU
THETRAN   THETRAN CHOORANAM
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TODDY
(FOR PURIFICATION)
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MATERIALS AND METHODS
I. TEST DRUG
The following drugs used in the study were obtained and processed by
the methods prescribed in stand text book of siddha medicines.
Thetran chooranam
The chooranam was prepared by the method described in Sarabendirar
vaithya muraigal shayaroga ulaimaanthai sikicchai page no: 50.
II. SELECTION AND COLLECTION OF THE RAW MATERIALS:
1. The sample of thaalgam obtained from
Sample A - raw drug store at Nagercoil Tamilnadu
2. The sample of Thurusu obtained from raw drug store at Nagercoil
Tamil nadu.
3. The sample of Thetrankottai is obtained from raw drug store at
Nagercoil Tamilnadu.
4. Toddy was collected from palm tree at vallanaadu and it was filtered
using a cotton cloth.
5. Milk was collected from white coloured cow at Tirunelveli and it was
filtered using cotton cloth.
6. Lime stone was collected from raw drug store at Tirunelveli,
Tamilnadu
METHODS OF PURIFICATION AND DETOXIFICATION:
Method 1: (Gunapadam thaathu Jeeva vaguppu Pg No : 328)
Thalagam 35 gm was purified by placing it in between the slaked lime
then it was rinsed with toddy for 10 times and dried.
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Method 1: (Gunapadam thathu Jeeva vagupu Pg No : 552)
Roast thurusu, till it turns to white colour.
Method 3 : (Sarakku suthi muraigal Pg. No.17)
Thetrankottai is soaked in cow’s milk and heated then dried.
Preparation of Thetran chooranam :
Ingredients :
Purified thetran kottai - 8 palam (280 gm)
Purified thurusu - 4 palam (140 gm)
Purified thalagam - 1 palam (35 gm)
Method
The above said drugs were grinded together and made into a fine
chooranam.
Vehicle :
Honey
Dose
Verugadi Alavu (200mg approximately)
Indication :
Ulaimanthai (Intestinal tuberculosis)
77
PRELIMINARY BASIC, ACIDIC RADICALS AND BIOCHEMICAL
STUDIES:
Preparation of extract:
5 gram of sample was taken in a 250 ml of clean beaker and 50 ml of
distilled water was added to it. Then it was boiled well for about 10 min. Then it
is allowed to cool and filtered in a 100 ml volumetric flask and made up to 100
ml with distilled water. This preparation is used for the qualitative analysis of
acidic/ basic radicals and biochemical constituents in it.
Test for basic radicals
PROCEDURE OBSERVATION INFERENCE
Test for Potassium: A pinch of
sample is treated with 2ml of
sodium nitrate solution and then
treated with 2ml of cobalt nitrate
in 30% of glacial acetic acid.
Formation of Yellow
colour precipitate
Presence of
Potassium
Test for Calcium: 2 ml of extract
is taken in a clean test tube. To
this add 2 ml of 4% ammonium
oxide solution.
Formation of White
colour precipitate
Presence of
Calcium
Test For Magnesium: To 2ml of
extract, sodium hydroxide solution
is added in drops.
Formation of White
colour precipitate
Presence of
Magnesium
Test For Ammonium: To 2ml of
extract few ml of Nessler's reagent
and excess of sodium hydroxide
solution are added.
Appearance of
Brown colour
Presence of
Ammonium
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PROCEDURE OBSERVATION INFERENCE
Test For Sodium: 2 pinches of
the substance is made into paste
by using Hcl and introduced into
the blue flame of Bunsen burner.
Appearance of
intense Yellow
colour
Presence of
Sodium
Test for Iron (Ferrous) : The
extract is treated with Cone. HNO3
and ammonium thiocynate.
No blood red colour
is formed
Absence of
Ferrous iron
Test For Zinc: To 2ml of the
extract sodium hydroxide solution
is added in drops.
No white precipitate
is formed
Absence of Zinc
Test For Aluminium: To the 2ml
of the extract sodium hydroxide is
added in drops.
Characteristic
changes
Presence of
Aluminium
Test For Lead: 2 ml of extract is
added with 2ml of potassium
iodide solution.
Formation of yellow
colour precipitate
Presence of Lead
Test for Copper: a) one pinch of
substance is made into paste with
con. Hcl in a watch glass and
introduced into the non-luminous
part of the flame. b) 2 ml of
extract is added with   excess of
ammonia solution.
Formation of Blue
colour Precipitate.
Presence of
Copper
Test For Mercury: 2ml of the
extract is treated with 2ml of
sodium hydroxide solution.
Formation of Yellow
precipitate
Presence of
Mercury
Test for Arsenic: 2ml of the
extract is treated with 2ml of
sodium hydroxide solution.
Formation of
Brownish red
precipitate
Presence of
Arsenic
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Test for acidic radicals
PROCEDURE OBSERVATION INFERENCE
Test for Sulphate: 2 ml of the
extract is added to 5 % barium
chloride solution.
Formation of white
precipitate
Presence of
Sulphate
Test for Chloride : The extract is
treated with Silver nitrate solution.
Formation of White
precipitate
Presence of
Chloride
Test for Phosphate : The   extract
is treated with ammonium
molybdate  and cone. HNO3.
Formation of Yellow
precipitate
Presence of
Phosphate
Test for Carbonate : The
substance is treated with Cone.
HC1.
No brisk
effervescence is
formed
Absence of
Carbonate
Test for Fluoride & Oxalate:
2ml of extract is added with 2ml
of dil. acetic acid and 2ml calcium
chloride solution and heated.
Formation of cloudy
appearance
Presence of
Fluoride & Oxalate
Test For Nitrate: lgm of the
substance is heated with copper
turnings and concentrated H2SO4
and viewed the test tube vertically
down
Characteristic
changes
Presence of Nitrate
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Other constituents
PROCEDURE OBSERVATION INFERENCE
Test for Starch : The  extract  is
added with weak iodine solution.
Formation of blue
colour
Presence of Starch
Test for Reducing Sugar: 5 ml
of Benedict's qualitative solution
is taken in a test tube and allowed
to boil for 2 min. Add 8 to 10
drops of extract and again boil it
for 2min. The colour changes are
noted.
No Colour changes Absence Presence of Reducing
sugar
Test for Alkaloids: a) 2ml of the
extract is treated with 2ml of
potassium Iodide solution
Appearance of Red
colour
b) 2ml of extract is treated with
2ml of picric acid
Appearance of
Yellow colour
c) 2ml of the extract is treated
with 2ml of phosphotungstic acid
Appearance of white
precipitate
Presence of Alkaloids
Test for amino acids: Dilute
extract +2ml of Ninhydrin's soln.
Appearance of violet
colour
Presence of Amino acids
Test for Tannic acid : The
extract is treated with Ferric
chloride.
Formation of Blue
black precipitate
Presence of Tannic acid
Test for type of Compound:
2ml of the extract is treated with
2 ml of ferric chloride solution
Appearance of Green
colour
Appearance of Red
colour
Appearance of Violet
colour Appearance of
Blue colour
Presence  of Oxyquinole,
Epinephrine and Pyro catechol
Presence of Anti pyrine, Aliphatic
amino acids and Meconic acid
Presence of Apomorphine
Salicylate and Resorcinol
Presence  of  Morphine, Phenol
cresol and Hydroquinone
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INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION
SPECTROMETRY (ICP-OES)
Introduction
The elemental composition of a sample is often an important part of the
information needed to assess its properties. Hence there is a need for sensitive
scientific instrumentation like ICP-OES which plays a pivotal role in the
determination of these elements. ICP-OES is widely employed for the estimation
of metals and metalloids at trace, minor and major concentrations.
Principle
In this technique, the high temperature plasma source atomizes the sample
and excites the atoms resulting in emission of photons .The atoms of each
element in the sample emit specific wavelength of light. The emission spectrum
from the plasma is dispersed by an optical spectrometer, so that intensities of the
individual wavelength can be measured. The number of photons emitted is
directly proportional to the concentration of the element. The photon may be
detected either sequentially or simultaneously. Quantitative analysis is achieved
by measuring the intensity of these specific wavelengths and after performing
the calibration using known standards.
Extraction of information
Obtaining qualitative information, i.e., what elements are present in the
sample, involves identifying the presence of emission at the wavelengths
characteristic of the elements of interest. Obtaining quantitative information, i.e.,
how much of an element is in the sample, can be accomplished using plots of
emission intensity versus concentration called calibration curves. Typical
calibration graph is illustrated bellow
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Typical ICP Calibration curve
Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36
Sample preparation - Microwave Digestion
 Weigh 0.25g of test sample and transfer into a liner provided with
the instrument.
 Slowly add 9ml of Nitric acid or Sulphuric acid such that no piece
of sample sticks on the slides.
 Mix thoroughly and allow reacting for few minutes.
 Place the liner in the vessel jacket.
 Close the screw cap hand-tight in clockwise direction.
 Seal the vessel and place in the rotor fixed in microwave.
 Set temperature to 180°C for 5 minutes; hold at 180°C for least 10
minutes.
 Allow the vessels to cool down to a vessel interior temperature
below 60°C and to a vessel surface temperature (IR) below 50°C
before removing the rotor.
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 The digested sample was made upto 100ml with millipore water.
 If visible insoluble particles exist, solution could be filtered through
whalmann filter paper.
 Transfer the digested solution into plastic containers and label them
properly.
References:
1. OPTIMA 5000 SERIES Hardware Guide.
2. Concepts, Instrumentation and Techniques in Inductively Coupled
Plasma Optical Emission Spectrometry by Charles B. Boss and
Kenneth J. Fredeen
3. Handbook of Inductively Coupled Plasma Spectrometry By
Michael Thompson And J. Nicholas Walsh.
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FOURIER TRANSFORM - INFRA RED SPECTROSCOPY
PERKINELMER - SPECTRUM ONE
Introduction
Vibrational spectroscopy is an extremely useful tool in the elucidations of
molecular structure. The spectral bands can be assigned to different vibrational
modes of the molecule. The various functional groups present in the molecule
can be assigned by a comparison of the spectra with characteristic functional
group frequencies. As the positions of the bands are directly related to the
strength of the chemical bond, a large number of investigations including
intermolecular interactions, phase transitions and chemical kinetics can be
carried out using this branch of spectroscopy.
In IR spectroscopy, the resonance absorption is made possible by the
change in dipole moment accompanying the vibrational transition. The Infrared
spectrum originates from the vibrational motion of the molecule. The vibrational
frequencies are a kind of fingerprint of the compounds. This property is used for
characterization of organic, inorganic and biological compounds. The band
intensities are proportional to the concentration of the compound and hence
qualitative estimations are possible.
The IR spectroscopy is carried out by using Fourier transform technique.
Principle
Infra red spectroscopy involves study of the interaction of
electromagnetic radiation with matter. Due to this interaction, electromagnetic
radiation characteristic of the interacting system may be absorbed (or emitted).
The experimental data consist of the nature (frequency of wave length) and the
amount (intensity) of the characteristic tafliation absorbed or emitted. These data
are correlated with the molecular and electronic structure of the substance and
with intra- and inter molecular interactions.
85
FT-IR spectroscopy is used primarily for qualitative and quantitative analysis of
organic compounds, and also for determining the chemical structure of inorganic
materials. The region between 500-4000 wave numbers is referred to as the
finger print region. Absorption bands in this region are generally due to intra
molecular phenomena and are highly specific for each material. The specificity
if these bands allow computerized data searches to be performed against
reference libraries to identify a material.
Table of Characteristic IR Absorptions
Frequency, cm—1 Bond Functional group
3640-3610 (s, sh) O-H stretch, freehydroxyl alcohols,
phenols
3500-3200 (s,b) O-H stretch, H-bonded alcohols, phenols
3400-3250(m) N-H stretch primary, secondary amines,
amides
3300-2500(m) O-H stretch carboxylic acids
3330-3270 (n, s) -C(triple bond)C-H:
C-H stretch
alkynes (terminal)
3100-3000 (s) C-H stretch Aromatics
3100-3000 (m) = C-H stretch Alkenes
3000-2850 (m) C-H stretch Alkanes
2830-2695 (m) H-C = 0: C H stretch Aldehydes
2260-2210 (v) C(triple bond)N stretch Nitriles
2260-2100 (w) -C(triple bond) C stretch Alkynes
1760-1665 (s) C = 0 stretch carbonyls (general)
1760  1690 (s) C = 0 stretch carboxylic acids
1750-1735 (s) C = 0 stretch esters, saturated aliphatic
1740-1720 (s) C = 0 stretch aldehydes, saturated aliphatic
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Frequency, cm—1 Bond Functional group
1730-1715(s) C = 0 stretch alpliasbeta-unsaturated esters
1715 (s) C = 0 stretch ketones, saturated aliphatic
1710 1665 (s) C = 0 stretch alpha.bcta-unsaturated
aldehydes, ketones
1680-1640 (in) -C-C- stretch Alkenes
1650-1580(m) N-H bend primary amines
1600-1585(m) C-C stretch (in-ring) Aromatics
1550-1475 (s) N-O asymmetric stretch nitro compounds
1500-1400(m) C-C stretch (in-ring) Aromatics
1470-1450 (m) C-H bend Alkanes
1370-1350 (m) C-H rock Alkalies
1360-1290 (in) N-O symmetric stretch nitro compounds
1335-1250 (s) C-N stretch aromatic amines
1320-1000 (s) C-0 stretch alcohols, carboxylic acids,
esters, ethers
1300-1150 (m) C-H wag ( CH2X) alkyl halides
1250-1020 (m) C-N stretch aliphatic amines
1000-650 (s) =C-H bend Alkenes
950-910 (m) O-H bend carboxylic acids
910 665 (s,b) N-H wag primary, secondary amines
900-675 (s) C-II "oop" Aromatics
850-550(m) C-Cl stretch alkyl halides
725-720 (m) C-H rock Alkanes
700 610 (b,s) -C(triple bond)C-H: C-H bend Alkynes
690^515(m) C-Br stretch alkyl halides
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m = medium, w = weak, s = strong, n = narrow, b-broad, sh = sharp
Sampling techniques:
There are a variety of techniques for sample preparation depending on the
physical form of the sample to be analyzed.
Solid :        KBr or Nujol mull method.
Liquid : Csl / TIBr Cells
Gas : Gas cells
Experimental Procedure: Done at SAIF, IIT Madras, Chcnnai-36
KBr Method
 The sample was grounded using- an agate mortar and pestle to give
a very fine powder.
 The finely powder sample was mixed with about 100 mg dried
KBr salt.
 The mixture was then pressed under hydraulic press using a die to
yield a transparent disc ( measure about 13mm diameter and
0.3mm in thickness), through which the beam of spectrometer
passed.
REFERENCES:
1. Laboratory Methods in Infrared Spectroscopy
2. Edited by R.G.J. Miller and B.C. Stace (1994).
3. Colthup, N.B., Daly, L.H., and Wiberley, S.E., Introduction to
4. Infrared and Raman Spectroscopy. New York: academic. 1990.
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SCANNED ELECTRON MICROSCOPY (SEM)
A SEM is essentially a high magnification microscope, which uses a
focussed scanned electron beam to produce images of the sample, both top-down
and, with the necessary sample preparation, cross-sections. The primary electron
beam interacts with the sample in a number of key ways:-
 Primary electrons generate low energy secondary electrons, which
tend to emphasize the topographic nature of the specimen.
 Primary electrons can be backscattered which produces images
with a high degree of atomic number (Z) contrast.
 Ionized atoms can relax by electron shell-to-shell transitions,
which lead to either X-ray emission or Auger electron ejection.
The X-rays emitted are characteristic of the elements in the lop few
um of the sample.
The SEM is carried out by using FEI-Quanta FEG 200-High Resolution
Instrument.
Resolution : 1.2 nm gold particle separation on a carbon substrate
Magnification : From a min of 12x to greater than 1, 00,000 X
Application : To evaluate grain size, particle size distributions,
material homogeneity and inter metallic distributions.
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Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36
Sample preparation:
Sample preparation can be minimal or elaborate for SEM analysis,
depending on the nature of the samples and the data required. Minimal
preparation includes acquisition of a sample that will fit into the SEM chamber
and some accommodation to prevent charge build-up on electrically insulating
samples. Most electrically insulating samples are coated with a thin layer of
conducting material, commonly carbon, gold, or some other metal or alloy. The
choice of material for conductive coatings depends on the data to be acquired:
carbon is most desirable if elemental analysis is a priority, while metal coatings
are most effective for high resolution electron imaging applications.
Alternatively, an electrically insulating sample can be examined without a
conductive coating in an instrument capable of "low vacuum" operation.
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Table 1
Colour characters of Thetran Chooranam
S No Solvent used Under ordinary light Under ultra violet light
1 PPM Dark Yellow Dark Yellow
PPM-Powdered plant material
Table 2
Physicochemical properties of Thetran Chooranam
S.No. Parameters
Values obtained
(%w/w) Heavy/ toxic metals
1 Total ash value 8.59 Lead BDL
2 Acid insoluble ash 0.55 Cadmium BDL
3 Water soluble ash 8.7 Mercury BDL
4 Moisture content 10.4 Arsenic BDL
5 Foreign organic matter 5
6 Crude fibre content 15.2
7 Alcohol soluble extractive 7.2
8 Water soluble extractive 10.25
Table 3
Colour, nature and percent yields of extracts of Thetran Chooranam
S.
No.
Extract
Solvents Colour
TLC/GC
(PEAKS) Nature
%
Yield
(w/w)
SEM-Micro
graph partical
size range in
micron
pH
1 Water DarkYello 5 Solid 50
4 – 8
micron 7.1-7.5
Table 4
Preliminary phytochemical analysis of different extracts of Thetran Chooranam
S. No Phytoconstituents Aqueous
1 Alkaloids +
2 Saponins +
3 Glycosides +
4 Carbohydrates +
5 Triterpenoids +
+ = Present, − = Absent.
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SEM REPORT OF THETRAN CHOORANAM
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PRECLINICAL TOXICITY STUDIES
Introduction:
Standardization is a vital necessity for global acceptance of Siddha
Medicine. In order to standardize our medicine it is necessary to evaluate its
safety and also to find whether is possess toxic properties or not. So toxicity
studies are conducted on the animals like mice, albino rats etc.
While doing toxicological studies we need the help of following
departments.
 Medicinal botany and Pharmacognosy
 Pharmacology
 Biochemistry
 Histopathology
 Pharmacy
 Animal House
 Bio - Statistics
While doing animal study, there are some criteria and condition to be
noted.
They are given below.
Methodology:
Selection of animal species
The preferred rodent species is the rat, although other rodent species may
be used healthy young adult animals of commonly used laboratory strains should
be employed. Females should be nulliparous and non - pregnant. Each animal, at
the commencement of its dosing, should be between 8 and 12 weeks old and its
weight should fall in an internal within  20% of the mean weight of any
previously doses animals.
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Housing and Feeding conditions
The temperature in the experimental animal room should be 22°c ( 3°C).
Although the relative humidity should be at least 30% and preferably not exceed
70% other than during room cleaning the aim should be 50-60%. Lighting
should be artificial the sequence being 12 hours light, 12 hours dark. For feeding
conventional laboratory diets may be used with an unlimited supply of drinking
water.
Preparation of drug
 While doing animal study the dose of the drug given is determined
on the basis of body weight of the animal.
 In case of mice and albino rat, the dose of the drug should not
exceed more than 1 ml for 100 gm body weight.
 When water soluble drugs are given, it must be 2ml/100gm body
weight.
 The adjuvant (anubanam) should be free from toxicity.
PROCEDURE
a. Administration of drug
During drug administration care should be taken that the drug does not
enter into the respiratory passage. Before drug administration, the animal has to
be fasted. In case of mice and albino rat, the fasting period is 3hrs and 12 firs
respectively. The Weight of the animal has to be noted before drug
administration. Then the drug is administered to the animal. After administration
of the drug, the animal should be fed after a lapse of 1 to 2 hrs in mice and 3-4
hrs in albino rats.
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b. Number of animals and dose levels
The dose of the drug given in the animal depends upon
1. Body weight of the animal
2. Metabolic rate of the animal
While conducting acute toxicity study the number of animals in each
group should be five (i.e six groups). Animals of both sexes should be used. In
case of chronic toxicity study the animals are divided into 3 groups, each group
consisting of 5 animals.
c. Observation
In acute toxicity study, the animals are carefully observed during the first
30 minutes and then observed for 24hrs. with special attention given during the
first 4 hours. The times at which signs of toxicity appear and disappear are
important and should be recorded. Observations include changes in skin and fur,
eyes and mucous membranes, respiratory, circulatory, autonomic and central
nervous systems, somatomotor activity and behavior pattern.
For chronic toxicity study the animals have to be observed for 90 days or
sometimes up to 1 year.   Some researchers conduct the chronic toxicity study
for the whole life time of the animal.
Body weight of the animal
The weight of the animal must be taken four times during the course of
study.
 First before drug administration.
 After 1 week of drug administration.
 Then 2 weeks after drug administration.
 Finally at the time of sacrificing the animal.
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Toxicity study
After sacrificing the animal, the internal organs are sent for
histopathological studies and results were recorded.
Data and report
At the end of the animal study, the following data must be given.
 Number of animals selected for the study.
 Number of animals died due to the toxicity of the drug given.
 Number of animals sacrificed at the end of animal study.
 Changes in animal behaviour due to acute and chronic toxicity.
 Histopathological changes in the internal organs such as liver,
kidney, heart etc.
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ACUTE ORAL TOXICITY STUDY
PRECLINICAL TOXICITY STUDIES
The toxicity evaluation of THETRAN CHOORANAM was carried out
in two phases.
Phase I - Acute toxicity study.
Phase II - Chronic toxicity study.
A.Acute Oral Toxiciy Study
Animals
Wister albino rats bred in the animal house attached to the Post graduate,
Pharmacology Department, Government Siddha Medical College, Palayamkottai
were used.
Sex
Animals of both sex were used.
Weight
Animals weighing between 80 - 120 gms were selected.
Food and water
The animals were maintained with standard animal feed and water
ad -libitum.
Number of Animals
30 Rats divided into 6 groups each group consisting of 5 rats.
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Dose Levels
The following dose levels were fixed by presuming range of least toxic to
high toxic doses.
I Group Control
II Group 40mg/100gm body weight.
ID Group 80mg/100gm body weight.
IV Group 160mg/100gm body weight.
V Group 320mg/100gm body weight.
VI Group 640mg/100gm body weight.
Dose preparation
The drug was weighed and taken. Then the drug was suspended in equal
amount of honey and water by vigorous mixing. The preparation was done in
such a way that lml of suspension containing doses ranging from 40mg to
640mg of Thetran Chooranam.
Administration of drug :
The mixture was administered to the groups in a single oral dose using a
feeding needle. The doses 40mg, 80mg, 160mg, 320mg, 640mg were
administered to group 11, III, IV, V, VI respectively. The control group
(Group I) received an equal volume of the vehicle (honey). Animals were fasted
prior to dosing and also for a further period of 3-4hr after drug administration.
Observations were made and recorded systematically.
Route of administration
The drug was administered orally.
Observations:
The following details were recorded:
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I. Stimulation
 Hyperactivity
 Pyloerection
 Twitching
 Rigidity
 Irritability
 Jumping
 Clonic convulsions
 Tonic convulsions
II. Depression
 Ptosis
 Sedation
 Sleep
 Loss of traction
 Loss of pinna reflex
 Ataxia
 Loss of muscle tone
 Analgesia
III. Autonomic effect
 Straub tail
 Laboured respiration
 Cyanosis
 Blanching
 Reddening
 Abnormal Secretions.
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At the end of 24 hours the number of animals live or dead in each
group was noted and the approximate LD50 was determined.
RESULT
Did not produce any mortality at the dose level ranging from 40mg to
640mg/ body wt. of the animal.
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ACUTE AND CHRONIC ORAL TOXICITY
101
DISSECTION
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B.CHRONIC ORAL TOXICITY STUDY
Introduction
Thetran Chooranam is used in the treatment of Intestinal Tubercolosis.
Tuberculosis is a Chronic inflammatory and infectious disease the major
ingredient of this medicine is arsenic compound, which posess acute toxicity and
also produces cumulative chronic toxic symptoms. So it is necessary to perform
Chronic oral toxicity study on Wister albino rats.
Animals
Wister albino rats bred in the animals house attached to the Post graduate,
Pharmacology Department, Government Siddha Medical College, Palayamkottai
were used.
Sex
Animals of both sexes were used.
Weight
Animals weighing between 80-120 gms, were selected.
Food and water
The animals were maintained with standard animal feed and water
ad-libitum.
Number of Animals
15 rats divided into 3groups each group consisting of 5 rats.
Dose Levels
Preparation of dose and administration
Drug was suspended in equal amount of honey and water by mixing
vigorously. The preparation was made in such a way that 1ml of suspension
contained 40mg and 80mg of Thetran Chooranam for the groups taken. The
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mixture was freshly prepared everyday and administered every morning for 90
consecutive days. The control group received vehicle alone.
Selection of dose level
Two doses were selected from the acute toxicity study. These doses did
not have any acute toxicity effect and presumed to be safe for long term
administration in animals.
I Group Control
II Group 40mg/100gm body weight.
III Group 80mg/100gm body weight.
Route of administration
The drug was administered orally for about 3 months.
Observation
The following details were recorded before and after the drug
administration.
1. Body weight of the animal : weight of each rat was recorded on
day 0, at weekly intervals throughout the course of study.
2. Food and water consumption : Changes in food and water
consumption was noted.
3. Clinical signs: All animals were observed daily for clinical signs.
The time of onset, intensity and duration of these symptoms if any
were recorded.
4. Mortality: All animals were observed twice daily for mortality
during entire course of study.
5. Haematological investigations : Changes in haematological
parameters were recorded.
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a) W.B.C Total count
b) W.B.C Differential count
c) Haemoglobin
Every month and at the end of the experiment, the above parameters were
recorded and the results were tabulated.
One animal from each group, were sacrified at the end of the experiment
and were dissected.   The Liver, Kidney and Heart were removed from each
animal and was preserved in 40% formalin solution send for Histo-pathological
studies.
Histopathological procedure
The sections were stained with haemotoxylin & eosin and the
histopathological report was given by Prof. Dr. K. Swaminathan MD,
Department of Pathology, Tirunelveli Medical College.
The tabular column shown that include the tested parameters and changes
in histopathological specimens were also documented.
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REPORT
Histopathological Picture in Low Dose Exposure :
Liver : Section studied shows liver tissue with mild
sinusoidal dilatation with focal congestion.
Kidney : Section studied shows normal glomeruli with focal
interstitial edema
Heart : Section studied shows normal bundles of myocardial
fibers.
Histopathological Picture in High Dose Exposure :
Liver : Section studied shows liver tissue with focal necrosis
and mild sinusoidal dilatation
Kidney : Section studied shows normal glomeruli with focal
interstitial edema with inflammatory cell infiltration
Heart : Section studied shows normal bundles of myocardial
fibers.
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RESULTS AND INFERENCE
Physico Chemical Evaluation
Table  1
Test for Basic Radicals.
S.No Procedure Sample C
1. Test for Ammonium -
2. Test for Sodium -
3. Test for Magnesium -
4. Test for Aluminium -
5. Test for Pottassium +
6. Test for Calcium +
7. Test for Ferrous Iron -
8. Test for Copper -
9. Test for Zinc -
10. Test for Arsenic +
11. Test for Mercury -
12. Test for Lead -
Sample - c- Thetran chooranam
From, the table 1, the sample C contains Pottassium, Calcium and
Arsenic, toxic heavy metals mercury, copper and lead are absent in this sample.
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Table 2
Test for Acidic Radicals
S.No Procedure Sample C
1. Test for Sulphate +
2. Test for Chlorides -
3. Test for Phosphate +
4. Test for Fluroide and Oxalate -
5. Test for Nitrate -
Sample c- Thetran chooranam
From the table 2, the sample c, contains sulphate and phosphate. But the
sample does not contain nitrate and fluoride.
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Table 3
Other constituents
S.No Procedure Sample C
1) Test for Starch +
2) Test for Reducing Sugar -
3) Test for Alkaloids -
4) Test for Amino acids +
5) Test for Tannic acids +
6) Test for type of compounds. -
From the table 3, the sample C contains starch, Aminoacids and Tannic
acid. Sample C - Thetran chooranam.
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Inductively Coupled Plasma Optical Emission Spectrometric studies
Table 4
Sample Thurusu (Before Purification)
Elements Analyte Sample A. (mean mg/c)
As 193.696 BDL
Cd 226.502 BDL
Hg 253.652 BDL
Cu 324.754 250.326 mg / L
Pb 230.204 BDL
S 181.975 78.285 mg / L
Inductively Coupled Plasma Optical Emission Spectrometric studies
Table 5
Sample Thurusu (After Purification)
Elements Analyte Sample A. (mean mg/c)
As 193.696 BDL
Cd 226.502 BDL
Hg 253.652 BDL
Cu 324.754 150.142 mg / L
Pb 230.204 BDL
S 181.975 59.298 mg / L
Result of this table shows that the copper and sulphur level was reduced
than that of which was present in the raw material.
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Inductively Coupled Plasma Optical Emission Spectrometric studies
Table 6
Raw sample (Before Purification)
Elements Analyte Sample A. (mean mg/c)
As 193.696 250.674
Ca 317.933 8.36 mg / L
Cd 226.502 BDL
Hg 253.652 BDL
Fe 238.204 9.855 mg / L
K 766.490 8.412 mg / L
Na 589.592 10.852 mg / L
P 214.914 13.129 mg / L
Pb 230.204 BDL
S 181.975 75.844 mg / L
BDL - Below detection limit.
Result of Table shows that all the raw samples of Thalagam have the
presence of Arsenic as a major component, Iron and sodium as a trace
component, mercury, cadmium, lead were found to be under the detection
limit.
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Table 7
Samples after purification and Thetran chooranam.
Element Sample B Sample C
As 120.847 mg / L BDL
Ca 4.651 mg / L 20.75 mg / L
Cd BDL BDL
Hg BDL BDL
Fe 5.111 mg / L 12.484 mg / L
K 8.412 mg / L 50.256 mg / L
Na 5.434 mg / L 15.257 mg / L
P 6.975 mg / L 19.54 mg / L
Pb BDL BDL
S 52.458 mg / L 12.51 mg / L
Sample - B - After purification of Thalagam. Sample - C - Thetran
chooranam.
The result of table shows that the sample after purified using toddy and
lime stone, has the presence of Pottassium, Phosphorus and sulphur. Further, this
table depicts that the finished medicinal sample thetran chooranam has heavy
metal concentration under the detection limit and has required concentration of
nutritional essential minerals.
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Table 8
Fourier Transform - Infra Red spectroscopic studies:
Sample c - Thetran chooranam
Frequency, cm - 1 Sample c
3640-3610(s,sh) -
3500-3200(s,b) +
3400-3250) -
3300-2500(m) +
3300-3270 -
3100-3000(s) +
3100-3000(m) -
3000-2850(m) +
2830-2695(m) -
2260-2210(v) -
2260-2100(w) -
1760-1665(s) +
1760-1690(s) +
1750-1735(s) -
1740-1720 -
1730-1715(s) -
1715(s) -
1710-1665(s) +
1680-1640(m) -
1650-1580(m) +
1600-1585(m) -
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Frequency, cm - 1 Sample c
1550-1475(s) +
1500-1400(m) +
1470-1450(m) -
1370-1350(m) -
1360-1290(m) -
1335-1250(s) +
1320-1000(s) +
1300-1150(m) +
1250-1020(m) +
1000-650(s) +
950-910(m) +
910-665(s,b) +
900-675(s) +
850-550(m) +
725-720(m) -
700-610(b,s) -
690-515)m +
The results of table shows the functional groups present in the sample.
Sample C constitutes alcohols, phenols, aromatics, alkanes, carboxylic acids,
carbonyls, alfa, beta - unsaturated aldehydes, ketones, primary amines, nitro
compounds, aromatic amines, esters, ethers, alkyl halides, aliphatic amines,
alkenes.
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Table 9
Shows the result of acute toxicity study of Thetran chooranam at a
control dose level
Observation At l hr At 2 hr At 4 hr At 24 hr
I. Stimulation:
Hyperactivity - - - -
Pyloerection - - - -
Twitching - - - -
Rigidity - - - -
Irritability - - - -
Jumping - - - -
Clonic convulsions - - - -
Tonic convulsions - - - -
II. Depression:
Ptosis - - - -
Sedation - - - -
Sleep - - - -
Loss of traction - - - -
Loss of pinna reflex - - - -
Ataxia - - - -
Loss of muscle tone - - - -
Analgesia - - - -
III. Autonomic effect:
Straub tail - - - -
Laboured respiration - - - -
Cyanosis - - - -
Blanching - - - -
Reddening - - - -
Abnormal Secretions - - - -
IV. Mortality
After 24 hrs: - - - -
115
Table 10
Shows the result of acute toxicity study of Thetran chooranam at
40mg/100gm dose level
Observation At l hr At 2 hr At 4 hr At 24 hr
I. Stimulation:
Hyperactivity - - - -
Pyloerection - - - -
Twitching - - - -
Rigidity - - - -
Irritability - - - -
Jumping - - - -
Clonic convulsions - - - -
Tonic convulsions - - - -
II. Depression:
Ptosis - - - -
Sedation - - - -
Sleep - - - -
Loss of traction - - - -
Loss of pinna reflex - - - -
Ataxia - - - -
Loss of muscle tone - - - -
Analgesia - - - -
III. Autonomic effect:
Straub tail - - - -
Laboured respiration - - - -
Cyanosis - - - -
Blanching - - - -
Reddening - - - -
Abnormal Secretions - - - -
IV. Mortality
After 24 hrs: - - - -
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Table 11
Shows the result of acute toxicity study of Thetran chooranam at
80mg/100gm dose level
Observation At l hr At 2 hr At 4 hr At 24 hr
I.Stimulation:
Hyperactivity - - - -
Pyloerection - - - -
Twitching - - - -
Rigidity - - - -
Irritability - - - -
Jumping - - - -
Clonic convulsions - - - -
Tonic convulsions - - - -
II.Depression:
Ptosis - - - -
Sedation - - - -
Sleep - - - -
Loss of traction - - - -
Loss of pinna reflex - - - -
Ataxia - - - -
Loss of muscle tone - - - -
Analgesia - - - -
III. Autonomic effect:
Straub tail - - - -
Laboured respiration - - - -
Cyanosis - - - -
Blanching - - - -
Reddening - - - -
Abnormal Secretions - - - -
IV. Mortality
After 24 hrs: - - - -
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Table 12
Shows the result of acute toxicity study of Thetran chooranam at
160mg/100gm dose level
Observation At l hr At 2 hr At 4 hr At 24 hr
I. Stimulation:
Hyperactivity - - - -
Pyloerection - - - -
Twitching - - - -
Rigidity - - - -
Irritability - - - -
Jumping - - - -
Clonic convulsions - - - -
Tonic convulsions - - - -
II. Depression:
Ptosis - - - -
Sedation - - - -
Sleep - - - -
Loss of traction - - - -
Loss of pinna reflex - - - -
Ataxia - - - -
Loss of muscle tone - - - -
Analgesia - - - -
III. Autonomic effect:
Straub tail - - - -
Laboured respiration - - - -
Cyanosis - - - -
Blanching - - - -
Reddening - - - -
Abnormal Secretions - - - -
IV. Mortality
After 24 hrs: - - - -
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Table 13
Shows the result of acute toxicity study of Thetran chooranam at
320mg/100gm dose level
Observation At l hr At 2 hr At 4 hr At 24 hr
I. Stimulation:
Hyperactivity - - - -
Pyloerection - - - -
Twitching - - - -
Rigidity - - - -
Irritability - - - -
Jumping - - - -
Clonic convulsions - - - -
Tonic convulsions - - - -
II. Depression:
Ptosis - - - -
Sedation - - - -
Sleep - - - -
Loss of traction - - - -
Loss of pinna reflex - - - -
Ataxia - - - -
Loss of muscle tone - - - -
Analgesia - - - -
III. Autonomic effect:
Straub tail - - - -
Laboured respiration - - - -
Cyanosis - - - -
Blanching - - - -
Reddening - - - -
Abnormal Secretions - - - -
IV. Mortality
After 24 hrs: - - - -
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Table 14
Shows the result of acute toxicity study of Thetran chooranam at
640mg/100gm dose level
Observation At l hr At 2 hr At 4 hr At 24 hr
I. Stimulation:
Hyperactivity - - - -
Pyloerection - - - -
Twitching - - - -
Rigidity - - - -
Irritability - - - -
Jumping - - - -
Clonic convulsions - - - -
Tonic convulsions - - - -
II. Depression:
Ptosis - - - -
Sedation - - - -
Sleep - - - -
Loss of traction - - - -
Loss of pinna reflex - - - -
Ataxia - - - -
Loss of muscle tone - - - -
Analgesia - - - -
III. Autonomic effect:
Straub tail - - - -
Laboured respiration - - - -
Cyanosis - - - -
Blanching - - - -
Reddening - - - -
Abnormal Secretions - - - -
IV. Mortality
After 24 hrs: - - - -
Result : From the above tables it has been found that the drug Thetran
Chooranam did not produce mortality even upto a dose level of 640mg/100gm
body weight of the animal. None of the animals in all the six groups showed any
abnormal signs in their behavioral pattern.
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Table  15
Body wt(g) of albino rats exposed to Thetran Chooranam for 90 days.
DaysDose
(mg/kg/day)
1 15 30 45 60 75 90
Control 100 100 102 102 104 104 104
40 100 96 98 96 102 104 104
80 100 94 96 99 98 102 102
Table 16
Changes in Hematological Parameters of Group I animals:
Control (vehicle - honey) (Mean values)
Parameter At 0 day At 30th day At 60th day At 90th day
Haemoglobin % 72% 72% 72% 74%
Leucocyte (xl06/ml) 9100 9000 9100 9200
Differential Count %
Neutrophils 49 54 53 52
Lymphocyte 48 43 44 44
Eosinophils 3 3 4 4
Basophils - - - -
Monocyte - - - -
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Table 17
Changes in Hematological Parameters of Group II (9a) animals :
40mg/100gm body weight of the animals. (Mean values)
Parameter At 0 day At 30th day At 60th day At 90th day
Haemoglobin % 70% 72% 72% 72%
Leucocyte (xl06/ml) 9300 9000 9200 9200
Differential Count %
Neutrophils 47 48 48 56
Lymphocyte 51 49 49 40
Eosinophils 2 3 4 4
Basophils - - - -
Monocyte - - - -
Table 18
Changes in Hematological Parameters of Group III (9b) animals:
80mg/100gm body weight of the animals, (mean values)
Parameter At 0 day At 30th day At 60th day At 90th day
Haemoglobin % 72% 72% 74% 74%
Leucocyte (xl06/ml) 9100 9000 9100 9200
Differential Count %
Neutrophils 49 54 51 24
Lymphocyte 48 42 45 72
Eosinophils 3 4 4 4
Basophils - - - -
Monocyte - - - -
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SECTION OF HEART
(Low Dose - 40mg / 100 gm body wt. of the animal)
(High Dose - 80mg / 100 gm body wt. of the animal)
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SECTION OF LIVER
(Low Dose - 40mg / 100 gm body wt. of the animal)
(High Dose - 80mg / 100 gm body wt. of the animal)
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SECTION OF KIDNEY
(Low Dose - 40mg / 100 gm body wt. of the animal)
(High Dose - 80mg / 100 gm body wt. of the animal)
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BIOSTATISTICAL ASPECTS ACUTE
ORAL TOXICITY STUDY
LD50 Measurement:
Biological assay refers to assessment of the potency of vitamins,
hormones, toxicants and drugs of all type by means of the responses produced
when doses are given to the experimental animals. In every dose response
situation, two components must be considered the stimulus and the subject.
The stimulus is applied to the subject as a stated dose namely
concentration, weight, time or appropriate measure. The subject manifest a
response, the level of intensity below which the response does not occur and
above which the response occur, such a value has often been called threshold.
But the term Tolerance K now widely accepted.
Median Effective Dose (ED50)
It is the dose which produces the desired effect in half the animal
population tested.
Median Lethal dose (LD50)
It is the dose which kills half the population of the animal tested.
LD 50 measurement (Toxicity)
 If that compound shows any mortality, then the LD50 of the drug is
determined.
 By determining the LD50, we can justify, whether to proceed with
the drug or not.
126
Table 19
Acute toxicity study Analysis
Groups Dose in mg/ 100gm body wt ofanimal No of rats
No of rats
died
II 40 5 -
III 80 5 -
IV 160 5 -
V 320 5 -
VI 640 5 -
Table 20
Chronic toxicity study Analysis
Groups Dose in mg/ 100gm bodywt of animal No of rats Days No of rats died
0 -
30 -
60 -
II 40 5
90 -
0 -
30 -
60 -
III 80 5
90 -
Result : Since there was no mortality of the animals in both acute and chronic
toxicity studies, lethal dose LD5o of the drug could not be calculated. From the
above biostatstical measures Thetran Chooranam was found to be safe upto the
dose level of 640mg/100gm body weight of the animal.
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Body Weight
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DISCUSSION
The mineral drugs were well equipped in treating the chronic symptoms.
In line with this the drug Thetran chooranam is used to treat Intestinal
tuberculosis.
The present study with Thetran chooranam was conducted with an
objective to find out, whether this drug has got any side effects or adverse
reactions in short and long term administration.
A brief outline of the study is given below for discussion. In the
qualitative anlaysis, the therapeutically valuable minerals like calcium
potassium, phosphate were present in the chooranam. Presence of aminoacids
and unsaturated compounds having additional valubility to that medicine.
ICP-OES analysis indicates that the amount of Arsenic and Sulplhur
present in Thetran chooranam was reduced below detection limit. (In raw
material, the arsenic level was 250mg / l). The copper and sulphur present in
Thetran Choornanam was in the acceptable range (1 mg/L and 12 mg/L
respectively). This indicates that the purification methods were proper and the
presence of sodium, phosphate, potassium, calcium, sulphur and Ferrous.
FT-IR analysis of Thetran chooranam indicates the presence of phenols,
carboxylic acids, aromatics, primary and secondary amines, ketone, aldehydes,
esters and alkyl halides. Thus the end product has high potentcy and therapeutic
values.
SEM analysis indicates that the particle size in Thetran chooranam has
300 m, the particles are distribute in micro range.
For the experimental purpose the doses selected for the acute and chronic
toxicity study in animal were relatively high when compared to the weight of the
human body .The aim of giving such high doses were find out the type of
toxicity, if the drug is given abnormality in high doses.
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The acute toxicity study of Thetran chooranam did not show either
mortality or any adverse reactions during the course of trial. All the animals did
not show any abnormalities in the behavioral pattern. This result indicated that
Thetran chooranam was non - toxic upto the dose level of 640 mg /100 gm
body weight.
On the basis of the acute toxicity results, the doses selected for the
chronic toxicity studies were 40mg / 100g of body weight and 80mg / 100gm
body weight of the animal. In chronic toxicity study no signs and symptoms of
toxicity were observed, and did not show any mortality during the course of trial.
The average intake of food and water for the test groups were slightly increased
from that of the control group.
At autopsy, macroscopically, the kidney liver, spleen, lungs and heart
showed no discoloration and the textures were consistent when compared with
the control groups.
Histopathological examination revealed that no pathological changes in
heart, liver tissues have normal hepatocytes with dilated sinusoids, and kidney
showed normal glomeruli with with focal intestial edema at 40mg/100g body
weight. At 80mg / 100g body weight dose level, the liver tissues showed
sinusoidal haemorrhages and no remarkable pathological changes in the heart.
These results indicate that Thetran chooranam upto 80mg/100g body
weight, showed minor changes in the liver and kidney. But there is mild
pathological changes in the heart following a 90 days drug administration.
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SUMMARY
 The drug “THETRAN CHOORANAM” is used by siddha physicians
for the treatment of Ulaimanthai.
 The aim of this dissertation is to study the acute and chronic toxicity of
the   drug Thetran   Chooranam administered at various presumed
moderate dosage, in the experimental animals.
 In Review of literature, the ingredients of Thetran Chooranam are
discussed in depth, with focus of special features and medicinal uses,
especially for Ulaimanthai.
 The bio-chemical studies of the drug bring out the presence of calcium,
starch and amino acid, copper.
 The drug was analysed for its physicochemical properties and contents by
using qualitative biochemical analysis and modern techniques such as
inductively coupled plasma-optical emission spectrometry.
 The ICP-OES analysis revealed heavy metals like Arsenic, Cadmium,
Mercury, Lead and Iron in below detection limit.
 By scanning electron microscope [SEM], the sizes of the particles about
5-10 micron, were analyzed.
 The preparation of the medicine "Thetran Chooranam" is given in the
previous chapter. The acute and chronic toxicity studies are done as
follows.
 For this study the Wister albino rats of both sexes were selected weighing
around 80-120 gms and were fed with standard food and water.
 The study was done at Pharmacology laboratory (PG), Government
Siddha Medical College, Palayamkottai.
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 To evaluate the acute toxicity study 30 rats were selected and divided into
6 groups (Group 1,11,111,1V,V,VI), each group consisting of 5 rats.
Among these one group is kept as control (Gr I) and they were
administered with the drug in different graded dosages ranging from
40mg, 80mg, 160mg, 320mg, 640mg / 100 gm body weight animal,
orally. The animals were observed and the details were recorded. The
drug did not produce any mortality even up to 24 hrs, so the drug is found
to be safe up to 640 mg / 100 gm body weight of animal on Acute
Toxicity.
 The chronic toxicity study was conducted for about 90 day's duration.
Two dose levels were selected from acute toxicity study for the drug
administration. For this study 15 rats were selected and divided into 3
groups, each group consisting of 5 rats.
 The first group kept as control by administered only with placebo or
water. Second group was administered with Thetran Chooranam at the
dose of 40mg / 100 gm body weight and the third group with 80 mg /100
gm body weight.
 The blood samples were taken before and during the drug administration
periodically (every 30 days) in chronic study. Then blood samples were
sent to laboratory for Haematological Evaluation. No significant
Haematological changes occurred.
 The weights of the animal were recorded before the beginning and during
the drug administration periodically. There is an increase in the body
weight and the results are statistically represented.
 One animal from each group were sacrificed at the end of the experiment.
The heart, liver, brain and kidney were removed from the animal and sent
to Histopathological study.
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 The result revealed that marked pathological changes in liver, kidney and
heart, which were presented in tables with relevant photos.
 On applying Bio-Statistical measures to the Acute and Chronic toxicity
studies, the drug Thetran Chooranam" is found to be Safe upto
640mg/body weight of the animal and the lethal dose of the drug Thetran
Chooranam' could not be calculated as there is no mortality of the
animals in the study.
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CONCLUSION
From the above studies, it was concluded that the drug “Thetran
Chooranam” produces mild histopathological changes in liver, kidney and heart
during long term administration in higher animal dose i.e., 80mg, but not in
lower dose. Hence this drug is always safe to the human, even in long term
administration with proper anupanam and pathiyam for the treatment of
Ulaimanthai.
This is just a preliminary study and I consider that the study will be
useful for further researches.
“There is no such thing as poison
It all depends on the dose”
- Goethe
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